Other local infections of skin and subcutaneous tissue

L12_INFECT_SKIN_OTHER

Tuberculosis, Cutaneous: Tuberculosis of the skin. It includes scrofuloderma and tuberculid, but not LUPUS VULGARIS.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints L12_PYODERMA L12_ERYTHRASMA L12_INFECT_SKIN_NAS	5171
6. Filter based on genotype QC (FinnGen only)	4599

Control definitions (FinnGen only)

Control exclude: L12_INFECT_SKIN

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2

NAME	L12_INFECT_SKIN_OTHER
CONTROL_EXCLUDE	L12_INFECT_SKIN
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	L12_PYODERMA\|L12_ERYTHRASMA\|L12_INFECT_SKIN_NAS
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other local infections of skin and subcutaneous tissue based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	34982	15741	18936
Only index persons	29006	13360	15646
Unadjusted period prevalence (%)
Whole population	0.49	0.45	0.53
Only index persons	0.55	0.49	0.60
Median age at first event (years)
Whole population	47.14	48.83	45.62
Only index persons	47.11	49.03	45.48

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	4599	2342	2257
Unadjusted period prevalence (%)	0.93	0.83	1.03
Median age at first event (years)	55.55	53.12	58.07

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
4782: Matched controls
47820

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

7.8

320.5

468

656

J01FF01

ATC

clindamycin; systemic

3.2

316.6

1867

7917

S97

ICPC

Chronic ulcer skin

5.7

313.1

641

1268

L08.0

ICD-10 Finland

Pyoderma

63.1

307.7

573

103

A46

ICD-10 Finland

Erysipelas

4.5

307.7

1333

3821

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

67.8

307.7

2080

537

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

73.6

307.7

1944

441

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

9.4

294.9

364

415

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

10.6

289.6

326

328

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

6.2

278.5

512

912

SPAT1148

SPAT

Treatment of chronic ulcer or burn

3.4

221.0

936

3170

J01CF05

ATC

flucloxacillin; systemic

4.3

220.2

632

1638

J01DB01

ATC

cefalexin; oral

4.4

209.1

4359

33519

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

7.2

193.7

298

439

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

8.2

188.4

256

327

L03.9

ICD-10 Finland

Cellulitis, unspecified

10.0

184.9

215

225

NHQ40

NOMESCO Finland

Amputation of toe

10.8

178.7

196

189

68600

ICD-8 Finland

Other local infections of skin and subcutaneous tissue, Pyoderma

+∞

173.0

165

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

3.2

163.9

765

2715

E0000UV, ,

ATC

2.3

161.9

2350

14323

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

2.8

151.9

899

3630

L08.1

ICD-10 Finland

Erythrasma

57.0

149.1

C03CA01

ATC

furosemide; systemic

2.3

146.0

1632

8844

L30.9

ICD-10 Finland

Dermatitis, unspecified

2.4

144.0

1305

6455

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.9

143.0

774

2973

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

3.2

141.1

646

2256

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.9

140.9

744

2818

J01MA12

ATC

levofloxacin; systemic

2.4

130.4

1086

5145

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.1

129.5

2515

16667

S18

ICPC

Laceration/cut

2.1

127.4

2488

16489

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

3.0

126.8

613

2203

TPH04

NOMESCO Finland

Cathetrisation of vein

2.3

125.1

1285

6651

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

5.0

124.2

274

569

S76

ICPC

Skin infection other

3.7

121.7

412

1186

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

10.9

119.6

129

121

N02AX02

ATC

tramadol; systemic, rectal

2.0

119.3

2236

14488

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

13.0

116.3

112

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

4.3

110.8

302

743

D07AC01

ATC

betamethasone; topical

2.0

107.0

1927

12180

J01MA02

ATC

ciprofloxacin; systemic

2.0

106.2

1998

12810

L89

ICD-10 Finland

Decubitus ulcer and pressure area

6.2

105.8

183

303

L03.0

ICD-10 Finland

Cellulitis of finger and toe

2.9

105.6

533

1954

R60.0

ICD-10 Finland

Localized oedema

2.5

104.9

752

3296

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

6.2

104.7

182

303

H02AB06

ATC

prednisolone; systemic

1.9

103.6

2422

16650

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

3.2

102.1

439

1467

A10AE04

ATC

insulin glargine; parenteral

2.7

99.7

599

2405

TQW80

NOMESCO Finland

Local dermatologic skincare

4.8

99.5

232

504

D07BA04

ATC

hydrocortisone and antiseptics; topical

2.6

98.3

628

2599

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

3.5

97.7

361

1097

QDA10

NOMESCO Finland

Incision of skin of lower limb

13.6

97.3

N02AA05

ATC

oxycodone; systemic

2.2

96.5

1003

5148

N03AX16

ATC

[U] pregabalin

2.1

95.0

1205

6671

A10AB05

ATC

insulin aspart; parenteral

2.9

94.5

499

1870

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.2

93.7

990

5108

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.5

92.5

637

2729

TQW11

NOMESCO Finland

Vacuum treatment of wound

5.5

90.7

179

336

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

4.8

90.6

207

442

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.3

89.9

795

3808

R50.9

ICD-10 Finland

Fever, unspecified

2.2

89.2

894

4507

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

16.1

89.0

D07AB02

ATC

hydrocortisone butyrate; topical

1.9

88.8

1531

9400

68698

ICD-8 Finland

Other local infections of skin and subcutaneous tissue, Aliae definitae

+∞

87.8

X59

ICD-10 Finland

Exposure to unspecified factor

2.1

85.9

1058

5767

J01DA01

ATC

[U] cefalexin

1.8

85.8

2955

22401

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.3

85.6

724

3396

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.7

85.6

497

1954

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.0

85.4

412

1467

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.9

84.3

1352

8079

D07AB08

ATC

desonide; topical

2.4

83.3

632

2824

L05.9

ICD-10 Finland

Pilonidal cyst without abscess

42.1

83.0

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

5.0

83.0

184

383

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.3

82.9

737

3529

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

6.3

82.8

142

233

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

5.0

81.9

178

364

E000001, ,

ATC

2.0

81.8

1046

5767

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.1

81.7

926

4882

A10AC01

ATC

insulin (human); parenteral

2.8

79.5

444

1709

L17

ICPC

Foot/toe symptom/complaint

1.9

79.4

1563

9940

L08

ICD-10 Finland

Other local infections of skin and subcutaneous tissue

5.3

79.0

162

315

ZZA00

NOMESCO Finland

Split skin graft

4.4

77.7

201

474

127

Kela drug reimbursment

Transplant complication

5.8

77.7

144

255

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.3

77.6

662

3109

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.8

77.3

1564

10016

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.9

77.2

1240

7379

103

Kela drug reimbursment

Diabetes, insulin-treated

1.9

77.1

1337

8155

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.9

76.3

1438

9000

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.8

73.4

1558

10090

D07AD01

ATC

clobetasol; topical

2.1

72.7

874

4691

S29

ICPC

Skin symptom/complaint other

1.9

72.6

1076

6216

L04AA06

ATC

mycophenolic acid; systemic

4.9

71.8

162

342

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

4.7

71.5

169

371

Z3231

NOMESCO Finland

Registered nurse

1.8

71.3

1367

8570

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.8

71.2

1807

12302

QBA10

NOMESCO Finland

Incision of skin of trunk

9.5

70.8

L30.3

ICD-10 Finland

Infective dermatitis

3.6

70.7

245

712

B18.2

ICD-10 Finland

Chronic viral hepatitis C

7.5

69.9

100

135

J01CE08

ATC

benzathine benzylpenicillin; parenteral

7.0

69.8

107

156

M79.6

ICD-10 Finland

Pain in limb

1.7

69.7

2130

15242

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

8.5

69.4

108

SPAT1255

SPAT

Intravenous administration of medicine

2.7

68.9

398

1555

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.0

68.9

982

5586

H3603, E103,

ICD-10 Finland

8.3

68.8

112

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.8

68.6

360

1338

Z94.0

ICD-10 Finland

Kidney transplant status

6.6

68.4

111

172

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

4.7

68.4

163

360

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.0

67.9

958

5427

NGQ20

NOMESCO Finland

Amputation of lower leg

12.6

67.5

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.7

67.5

392

1536

N03AX12

ATC

[U] gabapentin; oral

2.0

67.1

821

4424

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.0

66.9

842

4582

D09AB01

ATC

zinc bandage without supplements; topical

4.8

66.6

153

328

L02.8

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of other sites

6.0

65.8

117

199

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

3.2

65.3

267

861

ZXD05

NOMESCO Finland

Urgent procedure

1.8

65.0

1447

9433

D07AC13

ATC

mometasone; topical

1.8

64.9

1404

9077

P19

ICPC

Drug abuse

8.2

64.4

107

L28

ICPC

Limited function/disability (L)

1.9

64.2

945

5420

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

9.6

64.0

R06AE07

ATC

cetirizine; oral

1.7

63.8

2083

15058

L73.2

ICD-10 Finland

Hidradenitis suppurativa

7.5

63.6

123

P01AB01

ATC

metronidazole; oral, rectal

1.7

63.2

1834

12843

A10AB01

ATC

insulin (human); parenteral

3.5

62.7

222

654

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.1

62.6

690

3570

S10

ICPC

Boil/carbuncle

2.8

62.6

330

1229

TK800

NOMESCO Finland

Hemodialysis

4.4

62.5

158

366

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

4.8

62.4

141

298

B01AB05

ATC

enoxaparin; parenteral

1.7

62.3

1465

9680

R06.0

ICD-10 Finland

Dyspnoea

1.8

61.7

1326

8533

WX408

NOMESCO Finland

General anesthesy, balanced

1.8

61.5

1254

7947

Z49.1

ICD-10 Finland

Extracorporeal dialysis

5.7

61.1

114

203

AA1AD

NOMESCO Finland

CT of head and brain

1.7

60.7

1376

8983

A02BC02

ATC

pantoprazole; systemic

1.7

60.7

3194

25972

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

6.9

60.6

139

WX213

NOMESCO Finland

Lower leg blockade

7.4

60.5

121

TPH07

NOMESCO Finland

Cathetrisation of artery

2.2

60.2

602

2999

D07AA02

ATC

hydrocortisone; topical

2.0

59.9

728

3900

T36

ICD-10 Finland

Poisoning by systemic antibiotics

3.1

59.6

260

871

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.3

59.5

515

2420

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.6

59.2

2508

19242

J45.9

ICD-10 Finland

Asthma, unspecified

1.9

59.2

953

5611

A28

ICPC

Limited function/disability NOS

1.9

58.6

859

4905

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.4

58.6

442

1957

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

3.3

58.6

224

693

Z2446

NOMESCO Finland

Social worker

2.6

58.4

373

1529

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.6

58.0

353

1413

6860A

ICD-9 Finland

Other local infections of skin and subcutaneous tissue, Pyoderma

+∞

57.4

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.0

57.4

779

4333

N02AJ06

ATC

codeine and paracetamol; systemic

1.6

57.3

2059

15124

WX002

NOMESCO Finland

Sedation and analgesia

1.9

57.2

911

5338

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

5.1

57.0

122

246

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.5

57.0

402

1726

T79.3

ICD-10 Finland

Post-traumatic wound infection, not elsewhere classified

5.0

57.0

123

250

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

7.1

56.7

121

N02BE01

ATC

paracetamol; systemic, rectal

2.1

56.6

4212

37412

XF400

NOMESCO Finland

ECG with 12 standard connections

1.9

56.3

774

4321

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.2

56.0

505

2410

L20.0

ICD-10 Finland

Besnier prurigo

2.4

56.0

429

1911

ZXA00

NOMESCO Finland

Right side

1.7

55.8

1202

7704

ZX120

NOMESCO Finland

Intravenous

2.2

55.7

491

2322

A10AE05

ATC

insulin detemir; parenteral

2.7

55.4

305

1160

T89

ICPC

Diabetes insulin dependent

3.0

55.3

254

876

6869X

ICD-9 Finland

Other local infections of skin and subcutaneous tissue, Unspecified local infection of skin and subcutaneous tissue

+∞

55.3

R4110

NOMESCO Finland

Physiotherapy

1.7

55.2

1329

8782

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

11.8

55.0

D06AX01

ATC

fusidic acid; topical

2.2

54.8

485

2296

L04AD02

ATC

tacrolimus; systemic

5.9

54.8

171

SPAT1151

SPAT

Treatment of major wounds

6.1

54.8

161

SPAT1262

SPAT

Handing over of treatment supplies

1.9

54.5

833

4811

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.8

54.5

950

5718

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.7

54.4

180

507

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

3.2

53.9

217

693

A41.9

ICD-10 Finland

Sepsis, unspecified

3.3

53.8

214

678

SPAT1254

SPAT

Administration of medicine

1.9

53.7

734

4085

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

5.7

53.6

100

178

L05.0

ICD-10 Finland

Pilonidal cyst with abscess

19.3

53.6

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

4.5

53.4

131

296

J01DA09

ATC

[U] cefadroxil

1.7

53.3

1232

8038

R11

ICD-10 Finland

Nausea and vomiting

2.2

53.1

481

2298

TPX10

NOMESCO Finland

Implantation of vascular injection port

3.4

53.1

197

598

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.7

52.9

1128

7195

A10AB04

ATC

insulin lispro; parenteral

3.4

52.9

191

570

H02AB04

ATC

methylprednisolone; systemic

2.0

52.8

698

3838

A12AA04

ATC

calcium carbonate; oral

4.8

52.8

119

251

L30.4

ICD-10 Finland

Erythema intertrigo

5.0

52.7

115

236

M14.6*E10.6

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic neuropathic

21.8

52.5

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.6

52.5

2034

15114

L04AD01

ATC

ciclosporin; systemic

4.3

52.5

136

321

F19.24

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction

17.3

52.3

E66.01

ICD-10 Finland

Obesity due to excess calories

2.2

52.1

491

2383

JN3AD

NOMESCO Finland

Abdominal CT examination

2.0

52.1

680

3723

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.3

52.0

202

631

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.6

51.5

1953

14420

L02.0

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of face

5.6

51.2

179

ZXA05

NOMESCO Finland

Left side

1.7

51.1

1099

7015

QDB10, ,

SPAT

3.6

50.8

168

473

SPAT1263

SPAT

Sampling

1.6

50.8

1904

14006

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.1

50.3

547

2803

M86.6

ICD-10 Finland

Other chronic osteomyelitis

13.6

50.2

I50.9

ICD-10 Finland

Heart failure, unspecified

2.0

50.1

652

3562

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

9.3

50.1

137

Kela drug reimbursment

Uraemia requiring dialysis

6.5

49.8

129

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.2

49.6

466

2258

D07BC01

ATC

betamethasone and antiseptics; topical

2.0

49.4

590

3127

A10AA01, ,

ATC

3.7

49.4

160

444

V03AE01

ATC

polystyrene sulfonate; oral

5.2

49.2

102

200

R53

ICD-10 Finland

Malaise and fatigue

1.7

49.0

1218

8072

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.7

48.9

1081

6941

XF600

NOMESCO Finland

Bloodpressure measurement

2.4

48.8

349

1505

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

12.1

48.8

L04AA01

ATC

[U] ciclosporin

5.2

48.8

101

198

Z3226

NOMESCO Finland

Physiotherapist

1.8

48.4

854

5140

L04AX01

ATC

azathioprine; systemic

2.8

48.3

248

909

UJF32

NOMESCO Finland

Coloscopy

1.7

47.9

1188

7864

N05AH04

ATC

quetiapine; oral

1.8

47.9

860

5202

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

5.8

47.7

155

F15.2

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome

11.2

47.5

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

10.5

47.3

WZC00

NOMESCO Finland

Treatment plan or consultation

1.6

47.2

1755

12825

S21

ICPC

Skin texture symptom/complaint

1.8

47.0

754

4404

G63.2*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic polyneuropathy

14.0

46.8

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.7

46.8

262

1005

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

6.1

46.5

135

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

4.4

46.1

118

276

E000002, ,

ATC

2.0

46.0

536

2812

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.3

45.6

352

1570

M14.6*A52.1

ICD-10 Finland

Charcot's or tabetic arthropathy

17.7

45.5

A06AD11

ATC

lactulose; oral

1.9

45.2

686

3935

J02AC01

ATC

fluconazole; systemic

1.6

45.2

1670

12155

X58

ICD-10 Finland

Exposure to other specified factors

1.8

45.2

739

4339

L01.0

ICD-10 Finland

Impetigo [any organism] [any site]

4.5

44.8

109

245

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

6.4

44.8

117

A10AA02, ,

ATC

3.2

44.7

184

595

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

6.5

44.7

114

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.7

44.4

254

984

N05BA04

ATC

oxazepam; oral

1.6

44.2

1192

8034

SPAT1211

SPAT

Application of soft bandage

2.1

44.1

430

2111

SPAT1301

SPAT

No procedures

1.6

43.8

1394

9780

A11CC03

ATC

alfacalcidol; systemic

3.5

43.8

152

442

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.8

43.8

743

4408

L03.3

ICD-10 Finland

Cellulitis of trunk

7.6

43.7

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

6.8

43.6

101

XCK10

NOMESCO Finland

Photography of fundus of eye

2.1

43.6

452

2271

C03DA01

ATC

spironolactone; oral

1.9

43.6

581

3192

Z72.2

ICD-10 Finland

Drug use

8.7

43.5

A01

ICPC

Pain general/multiple sites

2.0

43.5

506

2652

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.9

43.5

640

3632

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.6

43.5

1367

9562

D07CC01

ATC

betamethasone and antibiotics; topical

1.9

43.4

598

3320

J01AA07

ATC

tetracycline; systemic

1.8

43.4

684

3966

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

3.3

43.3

164

504

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

4.0

43.1

122

308

XQ848

NOMESCO Finland

Dermatological photography

3.1

42.8

181

595

S19

ICPC

Skin injury other

2.8

42.7

227

847

N06AX21

ATC

duloxetine; oral

1.9

42.6

574

3164

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

7.7

42.5

M04AA01

ATC

allopurinol; systemic

1.9

42.3

614

3467

S91.3

ICD-10 Finland

Open wound of other parts of foot

3.4

42.2

157

477

D64.9

ICD-10 Finland

Anaemia, unspecified

2.0

42.2

527

2830

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.9

42.2

621

3522

ZXE10

NOMESCO Finland

More than one and less than three hours

1.6

42.1

1565

11363

M14.6*E11.6

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic neuropathic

16.8

41.9

J01MA14

ATC

moxifloxacin; systemic

2.1

41.8

444

2249

R52.9

ICD-10 Finland

Pain, unspecified

2.0

41.7

514

2747

N05BA01

ATC

diazepam; systemic, rectal

1.9

41.6

597

3356

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.0

41.4

468

2425

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.6

41.0

1119

7544

N02BF02

ATC

pregabalin; oral

2.2

41.0

357

1674

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.0

41.0

463

2399

D07XC01

ATC

betamethasone; topical

1.9

40.9

581

3256

T90

ICPC

Diabetes non-insulin dependent

1.6

40.8

1092

7325

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

7.5

40.7

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

2.0

40.7

521

2820

XQ802

NOMESCO Finland

Epicutan test

2.8

40.6

216

806

B05DA

ATC

Isotonic solutions

6.3

40.6

109

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

40.6

1056

7033

R60.9

ICD-10 Finland

Oedema, unspecified

2.4

40.5

291

1256

L73.8

ICD-10 Finland

Other specified follicular disorders

5.2

40.3

162

N06AX11

ATC

mirtazapine; oral

1.5

40.0

1538

11221

F19.25

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances continuously used

15.3

40.0

V03AE02

ATC

sevelamer; oral

7.8

40.0

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.7

39.9

230

894

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.7

39.9

840

5288

C07AB07

ATC

bisoprolol; oral

1.5

39.8

2113

16501

SPAT1229

SPAT

Assessment of need for aid

2.2

39.8

353

1667

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.0

39.7

466

2446

E000003, ,

ATC

2.6

39.6

233

915

QCB10

NOMESCO Finland

Major dressing of wound of skin of upper limb

3.6

39.5

134

384

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.9

39.5

187

656

Z2221

NOMESCO Finland

Medical doctor

1.6

39.4

1215

8423

J01CF02

ATC

cloxacillin; systemic

3.6

39.4

132

375

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

39.3

1335

9464

QCA10

NOMESCO Finland

Incision of skin of upper limb

12.8

39.2

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

4.6

39.2

205

N05BB01

ATC

hydroxyzine; systemic

2.3

38.9

308

1387

N06AB04

ATC

citalopram; systemic

1.7

38.9

914

5922

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

6.3

38.9

104

I50.0

ICD-10 Finland

Congestive heart failure

2.2

38.9

343

1616

WX892

NOMESCO Finland

Monitored bed care

2.1

38.8

381

1872

N18.8

ICD-10 Finland

Other chronic renal failure

3.4

38.7

139

413

E000006, ,

ATC

2.3

38.7

322

1481

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

4.1

38.7

108

270

N05CF01

ATC

zopiclone; oral

1.6

38.6

1396

10032

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

6.0

38.5

115

D02AE01

ATC

carbamide; topical

2.3

38.5

319

1465

M10.9

ICD-10 Finland

Gout, unspecified

2.2

38.4

353

1690

N18.0

ICD-10 Finland

End-stage renal disease

5.4

38.3

140

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.2

38.1

329

1536

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

38.1

1280

9040

I83.2

ICD-10 Finland

Varicose veins of lower extremities with both ulcer and inflammation

7.0

38.1

N30.0

ICD-10 Finland

Acute cystitis

1.7

38.1

761

4718

WX402

NOMESCO Finland

General anaesthesia

1.6

38.0

1050

7080

B05DB

ATC

Hypertonic solutions

6.5

37.9

WX110

NOMESCO Finland

Infiltration anesthesia

1.5

37.9

3306

28444

H02AB07

ATC

prednisone; oral

1.8

37.8

606

3522

TKC20

NOMESCO Finland

Catheterisation of bladder

2.2

37.7

333

1569

R03AC02

ATC

salbutamol; inhalant

1.5

37.7

2470

20042

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

6.9

37.7

R51.80

ICD-10 Finland

Headache

1.7

37.5

744

4602

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.0

37.3

169

578

A10BA02

ATC

metformin; oral

1.6

37.2

1241

8744

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.5

37.0

251

1055

E66.8

ICD-10 Finland

Other obesity

2.3

37.0

280

1237

ZY010

NOMESCO Finland

Hospital outpatient

2.4

36.9

272

1188

R4180

NOMESCO Finland

Podiatric therapy

4.6

36.8

191

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

3.4

36.7

134

403

J01AA02

ATC

doxycycline; systemic

1.5

36.6

3472

30276

JN4AD

NOMESCO Finland

Body CT examination

1.9

36.5

539

3052

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.8

36.5

662

3989

F11.24

ICD-10 Finland

Addiction-induced dependence caused by opiates active addiction

13.7

36.5

QXB99, ,

SPAT

3.0

36.2

163

556

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

36.1

648

3892

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.8

35.9

580

3376

B03XA02

ATC

darbepoetin alfa; parenteral

3.4

35.9

128

379

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.0

35.9

422

2215

N03AX09

ATC

lamotrigine; oral

2.4

35.8

246

1040

NF1AA

NOMESCO Finland

Hip X-ray examination

2.0

35.8

412

2146

N02BF01

ATC

gabapentin; oral

1.9

35.4

494

2745

J04AB02

ATC

rifampicin; systemic

4.5

35.4

193

H04AA01

ATC

glucagon; nasal, parenteral

3.3

35.3

135

418

Z71.8

ICD-10 Finland

Other specified counselling

1.5

35.2

1548

11548

J01XC01

ATC

fusidic acid; systemic

4.6

35.2

186

S20

ICPC

Corn/callosity

3.4

35.2

127

379

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.3

35.2

265

1168

ZXE00

NOMESCO Finland

One hour or less

1.5

34.9

1678

12741

F10.09

ICD-10 Finland

Alcohol intoxication UNS

3.4

34.8

126

377

H3601, E103,

ICD-10 Finland

5.8

34.5

110

S91.1

ICD-10 Finland

Open wound of toe(s) without damage to nail

4.1

34.5

235

SPAT1260

SPAT

Consultation of another employee

1.7

34.5

769

4900

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

3.6

34.3

116

332

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

2.7

34.1

194

749

J01FA06

ATC

roxithromycin; oral

1.5

34.1

1701

12996

M54.5

ICD-10 Finland

Low back pain

1.5

34.0

1638

12431

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.9

33.7

158

551

ZXD10

NOMESCO Finland

Scheduled procedure

1.5

33.7

1612

12209

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

2.6

33.7

208

837

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.0

33.7

392

2049

L84

ICD-10 Finland

Corns and callosities

2.7

33.6

185

703

J01AA04

ATC

lymecycline; systemic

1.8

33.6

594

3548

W19

ICD-10 Finland

Unspecified fall

1.9

33.5

466

2586

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.5

33.5

210

851

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

5.4

33.5

124

WVA20

NOMESCO Finland

Medicine administration

2.8

33.3

165

593

L12

ICPC

Hand/finger symptom/complaint

1.6

33.2

805

5235

S06

ICPC

Rash localized

2.2

33.1

276

1270

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.0

33.1

412

2204

Z3229

NOMESCO Finland

Other healthcare associate professional

2.0

32.7

384

2013

L40.0

ICD-10 Finland

Psoriasis vulgaris

2.5

32.6

219

916

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.6

32.6

110

314

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.5

32.5

214

888

N05CD07

ATC

temazepam; oral

1.8

32.4

489

2783

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

7.9

32.3

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

4.0

32.2

234

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

3.1

32.2

135

442

KA1AE

NOMESCO Finland

Kidney ultrasound examination

3.0

32.1

144

490

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

3.2

32.1

132

427

QWC00

NOMESCO Finland

Reoperation for superficial infection in surgery of skin

9.8

32.1

ZXE20

NOMESCO Finland

More than three and less than five hours

1.7

32.0

593

3586

G47.3

ICD-10 Finland

Sleep apnoea

1.6

32.0

1050

7330

WZC30

NOMESCO Finland

Teaching

1.7

32.0

756

4883

SPAT1153

SPAT

Removal of sutures

1.5

31.8

1328

9760

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.2

31.8

296

1423

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.9

31.8

149

520

177

Kela drug reimbursment

Insulin glargine 300 U / ml

3.4

31.6

113

335

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.5

31.6

207

856

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

3.1

31.4

134

443

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.1

31.4

309

1518

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.1

31.4

297

1437

WX320

NOMESCO Finland

Spinalanesthesy

1.5

31.4

1049

7351

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.4

31.2

220

941

205

Kela drug reimbursment

Chronic hypertension

1.5

31.2

1080

7624

A08

ICPC

Swelling

2.2

31.1

275

1296

A10AE06

ATC

insulin degludec; parenteral

2.6

31.0

181

709

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

4.4

30.8

181

N06AB03

ATC

fluoxetine; oral

1.8

30.8

534

3168

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.0

30.6

337

1725

M54.4

ICD-10 Finland

Lumbago with sciatica

1.6

30.6

798

5275

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

9.5

30.6

N06AX16

ATC

venlafaxine; oral

1.7

30.6

631

3930

N05AH03

ATC

olanzapine; systemic

2.1

30.5

306

1513

SPAT1312

SPAT

General health counselling

1.5

30.5

1363

10141

L04AX03

ATC

methotrexate; systemic

1.9

30.4

441

2477

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

9.8

30.3

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.8

30.3

461

2630

Z49.2

ICD-10 Finland

Other dialysis

5.4

30.2

110

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

3.7

30.2

259

N05AX12

ATC

aripiprazole; systemic

2.5

30.2

201

838

T82

ICPC

Obesity

2.4

30.1

204

857

C08CA01

ATC

amlodipine; oral

1.4

30.0

1616

12453

A07AA02

ATC

nystatin; oral

2.2

30.0

262

1228

N03AE01

ATC

clonazepam; systemic

2.2

30.0

270

1281

S01

ICPC

Pain/tenderness of skin

2.3

30.0

237

1066

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.6

29.9

857

5793

H3600, E103,

ICD-10 Finland

4.5

29.8

161

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

6.0

29.8

X57

ICD-10 Finland

Unspecified privation

3.1

29.7

126

415

L03.2

ICD-10 Finland

Cellulitis of face

7.6

29.7

A02BC05

ATC

esomeprazole; systemic

1.4

29.7

1727

13496

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.6

29.6

792

5264

UKC02

NOMESCO Finland

Cystoscopy

1.6

29.4

699

4514

D02AX

ATC

Other emollients and protectives

2.7

29.3

166

640

R02

ICPC

Shortness of breath/dyspnoea

1.7

29.3

606

3775

S06.0

ICD-10 Finland

Concussion

1.8

29.2

497

2929

A03FA01

ATC

metoclopramide; systemic, rectal

1.6

29.2

938

6502

N05AA02

ATC

levomepromazine; systemic

2.5

29.2

193

802

J01EA01

ATC

trimethoprim; systemic

1.5

29.2

1046

7427

F10.24

ICD-10 Finland

Alcohol depence active use

3.7

29.1

261

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

29.1

2023

16307

317

Kela drug reimbursment

Topical pimecrolimus and tacrolimus

3.6

28.9

267

L60.0

ICD-10 Finland

Ingrowing nail

2.2

28.8

238

1091

L03

ICD-10 Finland

Cellulitis

4.5

28.7

154

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.1

28.6

267

1285

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

9.8

28.5

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.7

28.5

574

3547

A41.8

ICD-10 Finland

Other specified sepsis

3.4

28.5

105

318

W22

ICD-10 Finland

Striking against or struck by other object(s)

2.0

28.2

321

1663

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.1

28.2

265

1279

6868X

ICD-9 Finland

Other local infections of skin and subcutaneous tissue, Other specified local infections of skin and subcutaneous tissue[ALIAE INFECTIONES LOCALES CUTIS ET SUBCUTIS]

+∞

28.1

QCB05

NOMESCO Finland

Revision of wound of skin of upper limb

5.2

28.1

110

E000007, ,

ATC

2.2

28.1

244

1141

F10.20

ICD-10 Finland

Alcohol dependence currently independent

3.2

28.1

112

356

R5110, ,

SPAT

1.9

28.0

383

2110

M00.9

ICD-10 Finland

Pyogenic arthritis, unspecified

4.2

28.0

182

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

28.0

1179

8643

SPAT1216

SPAT

Assessment of functional ability

1.7

27.9

633

4035

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.5

27.9

1177

8631

WXQ27

NOMESCO Finland

UVB narrow spectrum light therapy

3.9

27.8

209

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.9

27.7

374

2052

EBA00

NOMESCO Finland

Extraction of tooth

1.4

27.6

1625

12682

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.9

27.6

127

439

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

27.6

2576

21765

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.1

27.5

279

1385

RS220, ,

NOMESCO Finland

4.0

27.5

202

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.6

27.5

790

5332

F60.9

ICD-10 Finland

Personality disorder, unspecified

4.0

27.4

194

WX214

NOMESCO Finland

Plexus blockade at the ankle

6.4

27.3

D01AC02

ATC

miconazole; topical

1.9

27.3

338

1802

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.5

27.1

179

744

XQ800

NOMESCO Finland

Prick test

1.9

27.0

330

1752

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.9

26.9

338

1810

N03AG01

ATC

valproic acid; systemic, rectal

2.1

26.6

270

1341

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.4

26.6

2404

20148

R4190

NOMESCO Finland

Nutritional therapy

2.3

26.4

211

953

D11AH01

ATC

tacrolimus; topical

4.4

26.4

152

ZXA10

NOMESCO Finland

Bilateral

1.6

26.4

761

5137

TNH33

NOMESCO Finland

Custom moulded brace, ankle or foot

3.6

26.3

241

M25.5

ICD-10 Finland

Pain in joint

1.4

26.2

1426

10947

B01AA03

ATC

warfarin; systemic

1.6

26.2

770

5218

A02BC01

ATC

omeprazole; systemic

1.5

26.2

1130

8304

L30.0

ICD-10 Finland

Nummular dermatitis

2.3

26.2

198

874

X84

ICD-10 Finland

Intentional self-harm by unspecified means

9.4

26.2

I79.2*E11.5

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic peripheral angiopathy

9.4

26.2

F15.1

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use

9.4

26.2

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

4.1

26.1

179

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

26.0

1504

11671

A04

ICPC

Weakness/tiredness general

1.6

25.9

712

4752

QXA20

NOMESCO Finland

Skin abrasion, unspecified location

8.5

25.7

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.9

25.7

330

1780

Z02.7

ICD-10 Finland

Issue of medical certificate

1.9

25.7

350

1925

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.3

25.7

198

881

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

3.7

25.7

217

J05AB01

ATC

aciclovir; systemic

1.5

25.7

925

6553

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.9

25.6

317

1689

E87.5

ICD-10 Finland

Hyperkalaemia

3.2

25.6

101

319

NFQ20

NOMESCO Finland

Amputation of femur

5.3

25.6

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.7

25.5

457

2730

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

2.0

25.5

300

1571

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.3

25.5

206

935

D05BB02

ATC

acitretin; oral

2.9

25.5

120

420

NH1AD

NOMESCO Finland

Ankle and foot CT

2.9

25.5

122

431

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.7

25.4

542

3396

TNX34

NOMESCO Finland

Major custom molded cast, unspecified region

3.5

25.3

257

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.1

25.2

253

1251

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.7

25.2

466

2809

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.5

25.1

167

696

E10

ICD-10 Finland

Type 1 diabetes mellitus

3.2

25.1

100

318

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.8

25.1

392

2251

TQW40

NOMESCO Finland

Remowal of suture of skin

1.9

24.9

311

1662

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.6

24.9

568

3620

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

5.8

24.9

TQW99

NOMESCO Finland

Other minor procedure on skin

2.2

24.8

225

1070

A10BH05

ATC

linagliptin; oral

2.1

24.8

228

1090

A06AC01

ATC

ispaghula (psylla seeds); oral

1.5

24.7

1072

7873

69100

ICD-8 Finland

Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum

3.7

24.7

218

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

3.1

24.6

102

332

S04

ICPC

Lump/swelling localized

1.7

24.6

491

3022

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

2.6

24.5

142

554

M48.0

ICD-10 Finland

Spinal stenosis

1.7

24.4

503

3121

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

3.5

24.4

234

WX882

NOMESCO Finland

High dependency care

2.5

24.4

152

615

K07

ICPC

Swollen ankles/oedema

2.2

24.3

214

1006

A29

ICPC

General symptom/complaint other

1.6

24.3

591

3827

QXB10

NOMESCO Finland

Exchange of dressing for large skin wound, unspecified location

8.9

24.2

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

3.2

24.1

300

M03BC01

ATC

orphenadrine (citrate); systemic

1.5

24.1

931

6680

D11

ICPC

Diarrhoea

1.7

24.0

530

3347

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.5

24.0

989

7186

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

6.3

24.0

196

Kela drug reimbursment

Paricalcitol and cinacalcet

6.3

24.0

OAB50, ,

SPAT

1.8

23.9

367

2094

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.9

23.8

327

1802

F10.25

ICD-10 Finland

Alcohol dependence continuous use

3.2

23.8

292

WW200

NOMESCO Finland

Immunization

2.6

23.8

136

527

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

23.8

1039

7633

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

2.9

23.8

114

403

L03.8

ICD-10 Finland

Cellulitis of other sites

7.2

23.7

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

4.2

23.7

148

WX704

NOMESCO Finland

Intubation

1.8

23.7

364

2079

RD210, ,

NOMESCO Finland

3.0

23.7

102

340

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

23.6

2209

18481

J04BA02

ATC

dapsone; oral

5.9

23.5

ZXD35

NOMESCO Finland

Usual procedure

2.5

23.5

151

620

S11

ICPC

Skin infection post-traumatic

3.7

23.4

198

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.3

23.4

275

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

7.9

23.4

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

5.5

23.3

L21.8

ICD-10 Finland

Other seborrhoeic dermatitis

3.6

23.3

222

XQ855

NOMESCO Finland

Skin temperature measurement

7.0

23.3

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

3.2

23.3

281

N30.9

ICD-10 Finland

Cystitis, unspecified

1.9

23.2

285

1514

T74.1

ICD-10 Finland

Physical abuse

3.1

23.1

308

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

3.8

23.0

187

S09

ICPC

Infected finger/toe

2.4

23.0

157

663

R03BB04

ATC

tiotropium bromide; inhalant

1.7

23.0

416

2492

WX725

NOMESCO Finland

Noninvasive ventilation

2.0

22.9

260

1344

B01AC04

ATC

clopidogrel; oral

1.6

22.9

663

4467

M13.9

ICD-10 Finland

Arthritis, unspecified

1.9

22.9

326

1817

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.2

22.9

198

924

QDE35

NOMESCO Finland

Repair of skin defect in lower limb after surgery or injury

7.1

22.9

C08CA13

ATC

lercanidipine; oral

1.6

22.8

593

3900

L14

ICPC

Leg/thigh symptom/complaint

1.8

22.7

359

2066

R42

ICD-10 Finland

Dizziness and giddiness

1.5

22.7

958

6983

D05AX52

ATC

calcipotriol, combinations; topical

2.0

22.7

239

1203

L01.1

ICD-10 Finland

Impetiginization of other dermatoses

5.8

22.7

R33

ICD-10 Finland

Retention of urine

1.8

22.6

354

2032

A40.0

ICD-10 Finland

Sepsis due to streptococcus, group A

8.2

22.6

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

3.0

22.6

333

K02.1

ICD-10 Finland

Caries of dentine

1.4

22.4

2598

22388

SPAT1310

SPAT

Counselling related to known health issue

1.4

22.4

1307

10105

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

3.6

22.3

200

S22

ICPC

Nail symptom/complaint

1.9

22.3

303

1664

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.6

22.3

125

480

J01CA04

ATC

amoxicillin; systemic

1.4

22.3

3690

33640

JN4BD

NOMESCO Finland

Extensive body CT

1.7

22.3

420

2542

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

5.6

22.2

C09AA02

ATC

enalapril; systemic

1.5

22.2

758

5292

K08.3

ICD-10 Finland

Retained dental root

1.8

22.2

345

1976

Z00.0

ICD-10 Finland

General medical examination

1.5

22.2

821

5829

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

3.9

22.2

169

J01CE02

ATC

phenoxymethylpenicillin; oral

1.4

22.1

2970

26145

S81.9

ICD-10 Finland

Open wound of lower leg, part unspecified

4.2

22.1

139

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.7

22.1

462

2877

N07BB01

ATC

disulfiram; oral

2.2

22.0

195

920

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

3.0

21.9

323

L02.1

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of neck

5.5

21.9

N06AA09

ATC

amitriptyline; systemic

1.8

21.9

379

2240

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.0

21.9

261

1373

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.0

21.9

259

1359

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

21.8

1137

8612

69282

ICD-8 Finland

Other eczema and dermatitis, E microbis

7.7

21.7

Z49.0

ICD-10 Finland

Preparatory care for dialysis

3.9

21.6

163

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

3.6

21.6

195

TPX15

NOMESCO Finland

Removal of vascular injection port

5.7

21.6

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

3.7

21.5

191

S80.0

ICD-10 Finland

Contusion of knee

1.8

21.5

337

1935

ZYC01

NOMESCO Finland

Remote contact by phone

1.9

21.4

276

1491

H01

ICPC

Ear pain/earache

1.6

21.4

512

3298

Z29

ICPC

Social problem NOS

2.7

21.4

115

433

TNX92

NOMESCO Finland

Supporting bandage or orthosis of lower limb

3.0

21.4

328

A10BB12

ATC

glimepiride; oral

1.9

21.3

269

1443

M10.0

ICD-10 Finland

Idiopathic gout

2.3

21.3

169

762

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.4

21.3

148

630

R03AC13

ATC

formoterol; inhalant

2.1

21.1

210

1036

L03

ICPC

Low back symptom/complaint

1.4

21.1

1244

9619

R03DC03

ATC

montelukast; oral

1.5

21.1

688

4756

A10BH01

ATC

sitagliptin; oral

1.7

21.0

387

2329

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.7

20.9

441

2749

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

20.9

948

6995

SPAT1172

SPAT

Guidance concerning hydration

2.9

20.8

100

355

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.3

20.8

151

656

F61.0

ICD-10 Finland

Mixed personality disorders

3.2

20.7

255

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.1

20.7

210

1043

B01AB10

ATC

tinzaparin; parenteral

1.6

20.6

458

2895

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

3.2

20.6

251

WX290

NOMESCO Finland

Other blockage of nerve

1.3

20.6

2053

17214

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

2.0

20.6

215

1080

NK1XE

NOMESCO Finland

Other ultrasound examinnation of muscle or tendon

4.1

20.5

134

K59.09

ICD-10 Finland

Constipation, unspecified

1.8

20.5

301

1694

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.0

20.5

224

1144

L01BA01

ATC

methotrexate; systemic

2.3

20.4

158

705

P80

ICPC

Personality disorder

5.9

20.4

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

20.4

806

5790

A10AD01

ATC

insulin (human); parenteral

3.1

20.4

268

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.7

20.4

375

2255

A10BJ06

ATC

semaglutide; parenteral

2.0

20.3

234

1216

NH3CG

NOMESCO Finland

Extensive MRI of foot

4.8

20.3

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

3.8

20.3

166

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.2

20.3

181

856

R52.2

ICD-10 Finland

Other chronic pain

2.2

20.2

176

824

H36.00

ICD-10 Finland

Diabetic background retinopathy

3.4

20.2

209

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.4

20.2

966

7193

R06AX22

ATC

ebastine; oral

1.5

20.1

692

4831

T81.9

ICD-10 Finland

Unspecified complication of procedure

2.8

20.1

350

S71.1

ICD-10 Finland

Open wound of thigh

3.8

20.1

158

M03BX02

ATC

tizanidine; oral

1.3

20.1

2627

22876

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.6

20.0

563

3763

R06AE09

ATC

levocetirizine; oral

1.5

20.0

598

4053

R03BA02

ATC

budesonide; inhalant

1.5

20.0

741

5255

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.7

19.8

427

2676

H36.01

ICD-10 Finland

Diabetic maculopathy

3.4

19.8

207

E66.00

ICD-10 Finland

Metabolic syndrome

1.9

19.7

240

1271

QDB99

NOMESCO Finland

Other procedure for wound of skin of lower limb

5.8

19.7

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

19.7

1191

9226

RJ420, ,

NOMESCO Finland

6.3

19.7

WZA90

NOMESCO Finland

Other medical or dental certificate

1.4

19.7

974

7290

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.4

19.7

1111

8508

WW500

NOMESCO Finland

Blood transfusion

2.1

19.6

179

854

C08CA05

ATC

nifedipine; systemic

1.9

19.6

251

1352

J01XX08

ATC

linezolid; systemic

4.8

19.6

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.9

19.6

242

1289

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

4.0

19.5

139

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.4

19.5

974

7300

A03

ICPC

Fever

1.5

19.5

746

5319

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.0

19.5

222

1150

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

19.5

1709

14027

H3603, E113,

ICD-10 Finland

4.3

19.4

118

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

19.4

3171

28438

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.8

19.4

335

R20.2

ICD-10 Finland

Paraesthesia of skin

1.8

19.4

306

1761

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.7

19.3

384

2357

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

3.0

19.3

298

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.9

19.3

320

SPAT1240

SPAT

Therapeutic discussion

1.6

19.2

429

2712

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

3.3

19.2

216

Y96.9

ICD-10 Finland

Unspecified type of accident

2.8

19.2

348

H43.1

ICD-10 Finland

Vitreous haemorrhage

2.6

19.2

115

457

P29

ICPC

Psychological sympt/compl other

1.8

19.2

328

1931

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.1

19.2

190

936

H05BX01

ATC

cinacalcet; oral

4.9

19.2

T78.4

ICD-10 Finland

Allergy, unspecified

2.0

19.0

197

986

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.2

19.0

165

772

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.9

19.0

244

1316

N05CF02

ATC

zolpidem; oral

1.5

19.0

690

4868

P99

ICPC

Psychological disorders other

2.3

18.9

144

638

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.5

18.9

117

472

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.0

18.9

193

962

R03BA05

ATC

fluticasone; inhalant

1.5

18.9

740

5301

R5140

NOMESCO Finland

Monitoring the use of the aid

1.6

18.8

469

3046

P15

ICPC

Chronic alcohol abuse

2.3

18.8

145

646

R07.3

ICD-10 Finland

Other chest pain

1.6

18.8

441

2822

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

18.8

1673

13743

S80.1

ICD-10 Finland

Contusion of other and unspecified parts of lower leg

2.2

18.8

159

737

6851A

ICD-9 Finland

Pilonidal cyst, Without mention of abscess

+∞

18.8

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.9

18.7

253

1387

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.5

18.7

589

4032

3AC01, ,

NOMESCO Finland

3.8

18.7

148

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.8

18.7

292

1674

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.4

18.7

130

554

CKC12

NOMESCO Finland

Photocoagulation of retina

2.1

18.7

182

891

TNH31

NOMESCO Finland

Prefabricated orthosis, ankle or foot

3.7

18.7

162

UJF12

NOMESCO Finland

Enteroscopy through intestinal stoma

7.3

18.6

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

2.8

18.6

337

L73.9

ICD-10 Finland

Follicular disorder, unspecified

5.2

18.6

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.7

18.6

389

2420

B07.9

ICD-10 Finland

Verruca simplex

2.1

18.6

167

793

S17

ICPC

Abrasion/scratch/blister

2.5

18.5

115

465

E66.9

ICD-10 Finland

Obesity, unspecified

2.2

18.5

159

741

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.9

18.5

235

1263

QD9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in lower extremities, unspecified

4.9

18.5

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

2.4

18.5

123

514

C02AC05

ATC

moxonidine; oral

2.0

18.4

197

998

NH3BG

NOMESCO Finland

MRI of foot

4.7

18.4

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.6

18.4

402

2529

M05BA04

ATC

alendronic acid; oral

1.7

18.4

321

1902

GD1AD

NOMESCO Finland

Thorax CT examination

1.8

18.4

271

1528

N05AX08

ATC

risperidone; systemic

1.7

18.3

344

2078

R4120

NOMESCO Finland

Occupational therapy

1.8

18.3

280

1595

SFA10

NOMESCO Finland

One-surface restoration

1.3

18.3

2369

20479

A02BC03

ATC

lansoprazole; oral

1.4

18.3

1115

8632

IFC01, ,

SPAT

30.1

18.3

M86.8

ICD-10 Finland

Other osteomyelitis

16.2

18.3

N06AB10

ATC

escitalopram; oral

1.4

18.3

827

6082

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

6.6

18.3

K59.1

ICD-10 Finland

Functional diarrhoea

1.9

18.3

244

1333

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.3

18.2

140

623

L28.1

ICD-10 Finland

Prurigo nodularis

4.3

18.2

107

C10AC01

ATC

colestyramine; oral

2.4

18.2

120

499

M86.1

ICD-10 Finland

Other acute osteomyelitis

13.6

18.2

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.5

18.2

560

3815

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.4

18.2

863

6403

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

4.2

18.1

116

PE1AT

NOMESCO Finland

Femoral artery PTA

3.5

18.1

175

M01AE02

ATC

naproxen; oral, rectal

1.3

18.1

2393

20735

N05AD01

ATC

haloperidol; systemic

2.3

18.1

133

581

B01AB04

ATC

dalteparin; parenteral

2.0

18.1

211

1103

RS221, ,

NOMESCO Finland

3.1

18.0

246

N06AA12

ATC

doxepin; systemic

2.0

17.9

204

1057

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

1.9

17.9

213

1121

I89.0

ICD-10 Finland

Lymphoedema, not elsewhere classified

4.3

17.8

109

N02AC04

ATC

dextropropoxyphene; oral

2.2

17.8

144

656

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.5

17.7

631

4430

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.5

17.7

524

3538

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

17.7

1665

13754

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.0

17.7

187

944

N03AF01

ATC

carbamazepine; oral, rectal

2.0

17.6

203

1056

L40.8

ICD-10 Finland

Other psoriasis

4.0

17.6

123

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

3.5

17.6

169

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.7

17.5

344

2103

QBA99

NOMESCO Finland

Other local destruction of skin of trunk

4.9

17.5

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.2

17.5

156

738

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

6.5

17.5

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

3.7

17.4

151

WX212

NOMESCO Finland

Femoral plexus blockade

2.5

17.4

106

425

QDA25

NOMESCO Finland

Destruction of lesion of skin of lower limb

5.1

17.4

WX702

NOMESCO Finland

Supraglottic ventilation device

1.8

17.4

242

1340

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

17.4

954

7252

L85.3

ICD-10 Finland

Xerosis cutis

3.5

17.4

175

ZY000

NOMESCO Finland

Hospital inpatient

3.3

17.3

200

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

17.3

1583

13014

J01FA01

ATC

erythromycin; systemic

1.5

17.3

537

3664

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

5.6

17.2

A04AA01

ATC

ondansetron; systemic, rectal

1.7

17.2

332

2021

Y88.1

ICD-10 Finland

Sequelae of misadventures to patients during surgical and medical procedures

3.2

17.2

216

TKC10

NOMESCO Finland

Percutaneous puncture of bladder

3.3

17.2

201

N05AN01

ATC

lithium; oral

2.5

17.2

105

422

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.7

17.2

306

1823

Z50.1

ICD-10 Finland

Other physical therapy

1.9

17.1

220

1188

H3600, E113,

ICD-10 Finland

3.4

17.1

177

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

2.5

17.1

107

435

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.4

17.1

810

6002

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.0

17.1

187

956

XQ902

NOMESCO Finland

Other photography

3.3

17.0

192

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.9

17.0

224

1218

A40.8

ICD-10 Finland

Other streptococcal sepsis

3.7

17.0

149

J46

ICD-10 Finland

Status asthmaticus

2.3

17.0

123

534

H02AB09

ATC

hydrocortisone; systemic

2.4

17.0

118

503

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

2.6

17.0

360

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

4.0

17.0

122

SPAT1231

SPAT

Assessment of adjustments needed in living environment

2.9

17.0

287

R55

ICD-10 Finland

Syncope and collapse

1.6

16.9

435

2846

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.0

16.9

193

1002

RJ411, ,

NOMESCO Finland

5.0

16.9

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

2.7

16.8

350

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

4.6

16.8

CKC15

NOMESCO Finland

Panretinal photocoagulation

3.9

16.8

123

A07AA09

ATC

vancomycin; oral

3.1

16.7

230

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.8

16.7

276

1609

S87

ICPC

Dermatitis/atopic eczema

2.4

16.7

118

507

6861A

ICD-9 Finland

Other local infections of skin and subcutaneous tissue, Pyogenic granuloma

+∞

16.7

P18

ICPC

Medication abuse

4.2

16.7

102

SPAT1272

SPAT

Drug screening

6.5

16.6

R05

ICPC

Cough

1.4

16.6

1027

7956

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.4

16.6

1131

8895

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

2.6

16.5

353

R06AX27

ATC

desloratadine; oral

1.3

16.5

1182

9361

J45

ICD-10 Finland

Asthma

1.6

16.5

423

2764

M86.4

ICD-10 Finland

Chronic osteomyelitis with draining sinus

27.6

16.5

R81

ICPC

Pneumonia

2.1

16.4

164

811

J05AB11

ATC

valaciclovir; oral

1.5

16.4

583

4088

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

2.2

16.4

139

645

160

Kela drug reimbursment

exenatide

2.7

16.4

309

NF3AA

NOMESCO Finland

Femur X-ray examination

2.5

16.4

100

402

L72.1

ICD-10 Finland

Trichilemmal cyst

1.7

16.4

278

1634

J02AC02

ATC

itraconazole; systemic

1.4

16.4

673

4856

NHG24

NOMESCO Finland

Fusion of subtalar joint and between bones of ankle

4.8

16.3

B35.3

ICD-10 Finland

Tinea pedis

1.9

16.3

205

1098

SPAT1167

SPAT

Insertion of urinary catheter

2.2

16.3

130

588

PH2DE

NOMESCO Finland

Ultrasound examination of bloodflow in veins of lower extremity with Doppler method

2.3

16.3

117

506

V03AE03

ATC

lanthanum carbonate; oral

5.7

16.3

L30.8

ICD-10 Finland

Other specified dermatitis

2.3

16.3

129

582

E87.6

ICD-10 Finland

Hypokalaemia

2.1

16.3

148

706

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.6

16.3

376

2396

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.4

16.3

107

445

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.2

16.3

139

647

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.1

16.3

156

760

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.6

16.2

403

2613

Z00.8

ICD-10 Finland

Other general examinations

1.7

16.2

331

2044

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

2.2

16.2

143

674

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.0

16.2

188

981

WX003

NOMESCO Finland

Sedation or analgesia orally, rectally or intramuscularly without general anesthesia

4.0

16.2

113

D11AH02

ATC

pimecrolimus; topical

5.8

16.2

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.1

16.2

149

715

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.8

16.1

249

1423

R31

ICD-10 Finland

Unspecified haematuria

1.6

16.1

417

2730

C08CA02

ATC

felodipine; oral

1.6

16.1

355

2236

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.5

16.1

479

3237

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

4.7

16.1

N05AF03

ATC

chlorprothixene; systemic

2.4

16.1

108

454

A10BK01

ATC

dapagliflozin; oral

1.7

16.1

323

1988

SPAT1234

SPAT

Support of social functional capacity

1.9

16.0

208

1126

K10.3

ICD-10 Finland

Alveolitis of jaws

1.9

16.0

202

1084

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

2.4

16.0

107

449

R35

ICD-10 Finland

Polyuria

1.7

15.9

287

1715

L04.0

ICD-10 Finland

Acute lymphadenitis of face, head and neck

6.2

15.9

D01AE15

ATC

terbinafine; topical

1.7

15.9

288

1723

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.7

15.9

334

2079

M01AB05

ATC

diclofenac; systemic, rectal

1.3

15.8

2783

24834

SPAT1125

SPAT

Stoma care and guidance

2.9

15.8

254

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.4

15.8

871

6614

J01CA08

ATC

pivmecillinam; oral

1.3

15.7

1481

12185

B02.9

ICD-10 Finland

Zoster without complication

1.7

15.7

275

1630

H36.09*E11.3

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic retinopathy

4.3

15.7

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.1

15.7

144

690

A01AB09

ATC

miconazole; local oral

1.7

15.7

318

1962

E86

ICD-10 Finland

Volume depletion

2.4

15.6

110

472

R52.0

ICD-10 Finland

Acute pain

2.1

15.6

148

718

SFA30

NOMESCO Finland

Three-surface restoration

1.3

15.6

1735

14594

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.7

15.6

264

1550

L23.9

ICD-10 Finland

Allergic contact dermatitis, unspecified cause

3.6

15.6

139

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.9

15.6

205

1116

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.8

15.5

223

1247

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

1.9

15.5

202

1095

N06AB06

ATC

sertraline; oral

1.5

15.5

455

3064

SPAT1275

SPAT

Drug rehabilitation and replacement therapy of opioid-dependent person

5.0

15.4

O24.0

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent

3.3

15.4

179

K03.66

ICD-10 Finland

Tooth plaque

1.6

15.4

334

2096

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3042936) Bacteria identified in Isolate by Culture

1506

5561

3.49

321.59

3.2

1.9

—

(3007853) Bacteria identified in Skin by Aerobe culture

1517

4573

4.39

307.65

2.9

1.6

—

(3023368) Bacteria identified in Blood by Culture

2243

11231

2.88

273.11

6.9

4.3

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1338

6930

2.29

130.91

2.6

1.9

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3016

21548

2.08

124.32

9.2

6.7

10.63

11.93

umol/l

6.97

2909

20577

(3001604) Monocytes [#/volume] in Blood

3002

21448

2.07

123.25

10.0

6.4

0.61

0.58

e9/l

4.62

2635

18400

(3013115) Eosinophils [#/volume] in Blood

3075

22172

2.08

123.01

10.4

6.6

0.21

0.19

e9/l

4.53

2748

19350

(3013650) Neutrophils [#/volume] in Blood by Automated count

3253

23953

2.12

122.93

14.2

9.6

4.37

4.09

e9/l

7.64

2878

20717

(3006315) Basophils [#/volume] in Blood

3003

21499

2.07

122.05

10.0

6.4

0.04

e9/l

1.85

2636

18448

(3019198) Lymphocytes [#/volume] in Blood

3047

21944

2.07

121.65

10.1

6.4

1.85

1.92

e9/l

2.10

2750

19312

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2904

20605

2.04

120.14

13.8

7.4

1.21

mmol/l

4.67

2606

17870

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1057

5125

2.36

119.24

2.4

1.8

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1268

6649

2.23

118.69

4.3

2.6

2.28

2.32

g/l

1.89

1187

6156

(3022948) Iron [Moles/volume] in Serum or Plasma

1333

7134

2.20

118.60

4.3

2.6

11.62

13.32

umol/l

13.39

1264

6672

(3013826) Glucose [Moles/volume] in Serum or Plasma

3279

24398

2.09

117.92

9.3

5.1

7.02

6.65

mmol/l

12.16

3150

23092

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1191

6109

2.26

117.47

4.3

2.6

20.68

23.14

6.20

1119

5698

(3024561) Albumin [Mass/volume] in Serum or Plasma

2654

18443

1.99

113.97

8.6

5.2

34.69

35.85

g/l

19.77

2519

17331

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2655

18460

1.99

113.75

12.5

6.7

1.20

1.21

mmol/l

3.02

2506

17138

(3019069) Monocytes/Leukocytes in Blood

2785

19772

1.98

111.28

10.3

6.6

8.89

8.87

0.13

2655

18582

(3006504) Eosinophils/Leukocytes in Blood

2774

19711

1.97

110.04

10.2

6.6

2.85

2.84

0.04

2642

18502

(3002032) Base excess in Venous blood by calculation

905

4265

2.38

107.85

8.6

4.1

1.75

1.79

mmol/l

0.10

826

3703

(3018010) Neutrophils/Leukocytes in Blood

2783

19875

1.96

107.83

10.0

6.4

58.78

57.08

11.60

2676

19015

(3022096) Basophils/Leukocytes in Blood

2762

19708

1.95

106.90

10.3

6.6

0.67

0.68

0.36

2629

18494

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

986

4843

2.31

106.66

2.4

1.8

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

916

4359

2.36

106.66

8.4

4.0

5.89

5.81

kpa

1.69

895

4245

(3002030) Lymphocytes/Leukocytes in Blood

2817

20265

1.95

106.05

10.2

6.6

26.02

27.96

17.37

2703

19235

(3032080) INR in Blood by Coagulation assay

2665

18862

1.93

104.86

19.7

14.8

1.26

inr

0.26

2272

15752

(3012544) pH of Venous blood

920

4441

2.33

103.35

8.6

4.0

7.37

7.38

1.11

577

2535

(3014111) Lactate [Moles/volume] in Serum or Plasma

827

3859

2.38

100.16

11.6

8.2

1.28

1.32

mmol/l

0.56

811

3785

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

683

2973

2.51

96.11

2.0

1.7

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1254

7032

2.06

95.60

5.2

3.6

0.80

0.82

mmol/l

5.69

1191

6644

(3020779) Urea [Moles/volume] in Serum or Plasma

827

3942

2.33

94.97

13.9

7.5

11.05

9.57

mmol/l

7.09

797

3788

(3000991) Gas panel - Venous blood

805

3804

2.34

94.27

14.4

9.2

—

(3026008) Bacteria identified in Urine by Culture

1845

11924

1.89

92.24

4.3

3.2

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1514

9186

1.95

91.56

2.3

1.8

1.23

1.24

mg/l

0.05

1210

7054

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3823

31316

2.10

90.25

12.9

8.2

82.04

79.15

u/l

3.68

3690

29816

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1735

11089

1.89

89.02

3.2

2.3

2.88

2.77

mg/l

1.13

1557

9610

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1957

13025

1.85

88.07

4.1

2.6

57.02

66.13

u/l

0.81

1839

12114

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

586

2468

2.57

87.97

2.1

1.7

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1040

5623

2.09

86.36

12.8

6.2

1.09

1.05

mmol/l

4.12

992

5247

(3044640) Blood type and Crossmatch panel - Blood

1991

13394

1.83

85.95

3.8

2.4

—

(3024354) Oxygen [Partial pressure] in Venous blood

763

3655

2.29

85.94

7.1

3.6

4.80

4.58

kpa

1.93

744

3556

(3031040) Bacteria [#/volume] in Urine by Automated count

3378

26707

1.90

85.62

6.9

4.6

1444.88

1636.52

e6/l

0.05

369

(3000494) Fungus identified in Specimen by Culture

959

5062

2.12

84.69

1.8

1.5

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1891

12615

1.83

83.15

2.8

2.2

188.07

222.27

u/l

1.15

1805

11969

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2615

19239

1.79

82.44

4.0

2.8

—

estimate

—

(3002582) Erythrocytes [#/volume] in Urine

2003

13676

1.80

80.90

5.2

3.4

82.38

89.84

e6/l

0.05

1603

10441

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1244

7373

1.93

78.58

4.1

3.0

1.30

1.13

e6/l

0.52

721

3902

(3027801) Oxygen [Partial pressure] in Arterial blood

916

4906

2.07

77.07

10.9

8.1

12.04

12.53

kpa

2.22

878

4716

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

916

4908

2.07

76.98

10.9

8.1

5.15

5.09

kpa

0.92

878

4719

(3030467) Casts [#/volume] in Urine by Automated count

1772

11801

1.80

76.77

5.1

3.3

0.42

0.40

e6/l

0.13

1379

8655

(3018095) Leukocytes [#/volume] in Urine

2199

15609

1.76

76.30

6.1

3.9

121.03

93.85

e6/l

0.37

1654

11012

(3037467) Urinalysis macro (dipstick) panel - Urine

3463

28025

1.85

76.20

6.7

4.5

71.87

3.09

—

(3019977) pH of Arterial blood

913

4906

2.06

76.04

11.0

8.1

7.42

0.33

478

2676

(3003396) Base excess in Arterial blood by calculation

907

4875

2.06

75.42

10.8

8.0

0.62

0.91

mmol/l

1.32

766

3994

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

587

2657

2.38

74.76

9.9

4.3

24.20

24.17

mmol/l

0.07

581

2632

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1574

10198

1.81

74.21

3.7

2.4

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1150

6774

1.92

73.25

4.3

3.1

2.97

2.33

e6/l

1.16

626

3287

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

382

1432

2.81

71.73

2.4

2.2

540.59

465.02

ug/l

0.19

366

1352

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1757

11876

1.76

70.93

4.0

3.2

2158.64

1305.49

ng/l

4.77

1541

10200

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

3652

30320

1.87

70.60

6.0

4.3

14.98

11.45

mm/h

27.45

3451

28478

(36304419) Bacteria [Presence] in Urine

1685

11268

1.76

70.51

4.9

3.2

4.16

75.00

estimate

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

897

4910

2.02

70.45

4.6

4.7

241.10

242.41

u/l

0.08

872

4657

(3018418) pH of Serum or Plasma

1801

12285

1.75

70.22

7.7

4.1

7.39

7.40

1.34

1341

8795

(3016502) Oxygen saturation in Arterial blood

819

4359

2.06

69.42

11.4

8.5

95.40

95.72

0.69

793

4208

(3021960) Folate [Moles/volume] in Serum or Plasma

1723

11636

1.75

69.39

2.0

1.7

19.79

20.01

nmol/l

0.25

1506

9944

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

207

543

3.94

69.34

8.0

6.5

11.97

11.91

mg/l

0.05

199

511

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2427

18096

1.69

67.36

2.6

2.1

95.52

95.98

pmol/l

0.18

1357

9768

(3027945) Reticulocytes/Erythrocytes in Blood

878

4849

1.99

66.91

3.3

2.8

1.81

1.77

0.55

806

4331

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

483

2112

2.43

66.10

1.8

1.5

—

(3015736) pH of Urine

2356

17511

1.68

65.48

4.8

3.4

6.27

6.22

1.39

1320

9879

(3033658) Prothrombin time (PT) actual/Normal

1591

10647

1.74

65.25

7.4

4.3

88.07

89.25

1.08

1565

10428

(3004119) Hemoglobin [Mass/volume] in Venous blood

561

2640

2.27

64.81

6.7

3.5

124.11

130.04

g/l

7.12

551

2560

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

758

4020

2.05

64.49

2.9

2.3

0.20

0.21

g/l

2.88

703

3759

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1988

14177

1.69

64.28

4.6

3.3

31.92

35.82

u/l

1.51

1881

13422

(3002173) Hemoglobin [Mass/volume] in Arterial blood

763

4064

2.04

64.12

12.0

8.9

118.32

122.20

g/l

5.42

749

3970

(3000850) Epithelial cells [#/volume] in Urine

1438

9427

1.75

62.98

3.9

2.7

6.00

5.41

e6/l

0.75

1330

8599

(3009508) Creatinine [Moles/volume] in Urine

1992

14316

1.67

61.81

5.0

3.4

7.31

7.81

mmol/l

5.46

1701

12203

(3017143) Hepatitis C virus Ab [Presence] in Serum

882

5007

1.93

61.52

2.2

1.6

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

251

817

3.19

60.42

1.9

1.5

—

(3023520) Reticulocytes [#/volume] in Blood

704

3729

2.04

59.76

3.2

2.8

68.76

69.18

e9/l

0.11

506

2725

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1063

6462

1.83

59.66

3.0

2.3

29.91

29.65

0.78

1031

6289

(3026250) Tacrolimus [Mass/volume] in Blood

107

189

5.77

57.86

44.0

39.8

7.05

7.22

ug/l

0.26

172

(40758558) Short blood count panel - Blood

1778

12584

1.66

57.34

9.8

6.2

—

(3021601) Nitrite [Presence] in Urine by Test strip

2757

21761

1.63

57.18

5.3

3.8

0.00

estimate

1.34

548

4584

(3036481) Cortisol [Moles/volume] in Serum or Plasma

735

4012

1.98

57.15

2.7

2.3

363.32

376.75

nmol/l

1.00

696

3721

(40768443) Skin Pathology biopsy report

405

1758

2.42

56.04

1.4

1.2

—

(3035350) Ketones [Presence] in Urine by Test strip

2774

21990

1.62

55.98

5.3

3.8

9.69

4.32

estimate

0.55

554

4656

(3009261) Glucose [Presence] in Urine by Test strip

2785

22132

1.62

55.33

5.4

3.8

0.02

0.08

estimate

0.44

516

4363

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2425

18681

1.60

54.48

3.4

2.4

74.80

76.59

nmol/l

2.51

2230

17041

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

389

1681

2.43

54.31

2.2

1.9

1.87

2.22

ug/l

0.33

352

1496

(3026493) Urate [Moles/volume] in Serum or Plasma

1578

10953

1.66

54.17

3.9

2.8

355.00

342.58

umol/l

4.48

1391

9732

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

521

2562

2.16

53.54

13.3

10.1

24.06

24.24

mmol/l

0.66

501

2516

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

596

3093

2.06

53.12

7.4

4.1

114.71

88.42

ng/l

5.25

542

2694

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2562

20068

1.60

53.10

4.7

3.1

126.95

124.42

ug/l

0.21

2430

18833

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

316

1251

2.63

53.04

1.4

1.3

—

(3026782) Osmolality of Urine

1235

8086

1.71

52.63

4.2

2.9

517.57

538.83

mosm/kgh2o

2.95

1113

7112

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

423

1930

2.31

52.15

1.9

1.8

1.68

1.50

g/l

3.11

378

1666

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1224

8015

1.71

52.05

5.7

3.8

264.28

577.24

ng/l

1.47

963

6164

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

291

1142

2.65

49.66

2.1

1.7

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

623

3374

1.97

49.04

1.8

1.5

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

4411

40260

2.23

48.92

33.7

15.3

25.66

24.20

mg/l

2.50

3983

33002

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

492

2453

2.12

48.59

13.8

10.7

15.73

16.11

2.11

480

2362

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

821

4883

1.82

48.38

4.0

3.0

6.75

8.23

umol/l

2.13

735

4295

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

527

2702

2.07

48.31

14.2

10.3

0.63

0.09

522

2682

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

716

4087

1.88

48.08

3.7

2.5

33.65

49.65

u/l

0.75

623

3468

(3019309) Folate [Moles/volume] in Red Blood Cells

1043

6660

1.72

48.07

1.9

1.8

1198.36

1160.27

nmol/l

0.58

834

5086

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

320

1338

2.49

47.87

3.8

3.7

0.32

0.35

iu/ml

0.50

171

732

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

549

2875

2.03

47.46

5.9

4.2

5.21

5.13

kpa

1.33

533

2760

(3011397) Hemoglobin [Presence] in Urine by Test strip

1428

9943

1.62

46.97

5.0

3.7

0.11

0.14

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1817

13395

1.57

46.95

5.2

4.2

15.73

8.41

mg/mmol

4.37

1223

8465

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

486

2447

2.10

46.71

5.8

4.2

1.76

1.66

mmol/l

0.20

380

1806

(3012516) Albumin [Mass/volume] in Urine

1790

13165

1.57

46.64

4.4

3.5

75.13

46.88

mg/l

4.62

1277

8508

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1049

6778

1.70

46.03

2.1

1.7

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2031

15416

1.55

45.76

5.3

3.6

37.51

91.54

ng/l

1.08

1513

10522

(3009343) pH of Capillary blood

533

2802

2.02

45.49

5.9

4.3

7.41

1.30

465

2306

(3021589) Normoblasts [#/volume] in Blood

2368

18624

1.54

45.16

18.1

11.2

0.00

e9/l

0.05

1926

15128

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

205

712

2.96

44.04

4.2

3.4

461.38

1168.98

u/ml

0.74

(3037522) Nuclear Ab [Titer] in Serum

929

5879

1.72

43.74

1.5

1.4

561.62

519.55

titre

0.27

197

1245

(3009445) Proteinase 3 Ab [Units/volume] in Serum

373

1753

2.22

42.61

1.6

24.24

19.91

iu/ml

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

236

900

2.71

42.57

8.7

5.9

249.56

552.05

iu/ml

0.96

127

(3027273) Bicarbonate [Moles/volume] in Venous blood

383

1828

2.19

42.10

6.4

3.4

25.17

25.21

mmol/l

0.08

375

1760

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

273

1130

2.50

41.66

1.5

1.3

13.96

14.84

iu/ml

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

411

2025

2.13

41.65

6.7

3.9

50.79

48.20

1.25

406

1992

(3020630) Protein [Mass/volume] in Serum or Plasma

610

3454

1.88

41.61

3.4

2.7

65.61

66.49

g/l

1.90

562

3182

(3023183) Ammonium ion [Moles/volume] in Plasma

235

914

2.65

40.77

2.9

31.86

35.86

umol/l

1.29

209

829

(3014051) Protein [Presence] in Urine by Test strip

1611

11838

1.54

40.72

4.0

2.8

0.07

0.06

0.07

263

(3015377) Calcium [Moles/volume] in Serum or Plasma

1861

14126

1.52

40.37

4.6

3.5

2.35

mmol/l

0.30

1692

12910

(3028707) Methadone [Presence] in Urine by Screen method

202

736

2.82

39.75

6.7

2.4

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

4402

40777

2.00

36.91

36.9

18.0

139.33

139.68

mmol/l

16.66

4332

39976

(46235355) HIV 1 and 2 tests - Meaningful Use set

1173

8174

1.58

36.82

2.6

1.9

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

4407

40875

2.00

36.26

37.4

18.2

3.99

3.97

mmol/l

5.04

4332

39990

(3035947) Staphylolysin Ab [Units/volume] in Serum

163

4.91

36.02

1.2

1.1

5.56

4.17

iu/ml

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

101

254

4.04

35.89

1.7

1.5

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

248

1052

2.43

35.86

1.5

1.3

—

(3024928) Oxygen saturation in Venous blood

258

1119

2.38

35.51

7.4

3.6

64.04

61.85

0.78

249

1085

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

202

781

2.66

35.45

1.6

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

202

781

2.66

35.45

1.6

1.3

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

303

1417

2.22

34.92

1.6

1.4

—

(3022313) Gas panel - Capillary blood

389

2011

2.02

34.47

6.0

4.5

—

(3052851) Hemolysis interference index of Serum or Plasma

248

1073

2.38

34.31

4.3

3.2

1.44

2.51

index

1.15

143

557

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3574

31567

1.52

33.52

5.0

4.3

14.66

14.73

pmol/l

1.06

3298

29113

(3007164) IgA [Mass/volume] in Serum or Plasma

1219

8731

1.53

33.29

1.7

1.5

2.50

2.40

g/l

1.00

753

5480

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

279

1291

2.23

32.98

3.9

2.8

201.05

188.81

1.38

267

1235

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

311

1505

2.14

32.87

1.4

1.3

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

293

1403

2.16

31.80

3.5

2.8

92.89

92.53

0.09

280

1360

(3048689) Calprotectin [Mass/mass] in Stool

835

5535

1.62

31.79

2.7

2.5

162.87

129.41

ug/g

1.27

682

4464

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

358

1850

2.01

31.70

6.1

5.4

1.79

1.59

2.31

343

1745

(3005719) IgG [Mass/volume] in Serum or Plasma

563

3367

1.76

31.61

3.5

2.9

10.64

10.59

g/l

0.10

525

3092

(3007930) Methemoglobin/Hemoglobin.total in Blood

337

1708

2.05

31.49

6.2

5.6

0.86

0.89

0.60

324

1608

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

258

1189

2.24

30.79

1.4

1.3

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

187

4.28

30.46

2.2

1.4

2702244.00

1071654.90

iu/ml

—

(3036489) Thrombin time

326

1655

2.04

30.31

3.2

2.4

21.27

20.87

0.67

286

1480

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

318

1602

2.06

30.19

6.4

4.8

24.91

24.71

mmol/l

0.47

302

1488

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

649

4086

1.68

30.16

5.4

3.3

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

281

1352

2.15

30.12

4.0

3.0

3.84

3.50

g/l

3.02

270

1287

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

272

1299

2.16

29.71

2.2

1.7

1.19

1.18

g/l

0.12

258

1238

(3000475) Leukocytes [#/volume] in Synovial fluid

222

977

2.33

29.54

1.8

1.6

21386.71

12892.47

e6/l

0.93

141

672

(3030981) Hyaline casts [#/volume] in Urine by Automated count

557

3385

1.73

29.45

3.2

2.4

0.48

0.43

e6/l

0.16

534

3238

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

554

3363

1.73

29.40

2.8

2.3

6.08

7.65

ug/l

1.53

483

2987

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

264

1252

2.17

29.35

2.2

1.7

0.24

0.23

g/l

0.19

247

1191

(3045414) Leukocytes [Presence] in Urine

625

3941

1.67

28.79

2.6

2.1

0.00

0.01

estimate

1.06

119

844

(3010375) cycloSPORINE [Mass/volume] in Blood

183

4.20

28.67

29.6

111.09

117.51

ug/l

0.37

155

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

531

3215

1.73

28.40

3.7

3.0

233.41

186.21

ng/l

1.54

479

2914

(3019150) Specific gravity of Urine by Refractometry

1297

9669

1.47

28.32

5.5

3.9

1.02

1.33

kg/l

0.81

891

6409

(3017732) Neutrophils [#/volume] in Blood

779

5223

1.59

27.94

4.4

3.1

4.55

4.63

e9/l

0.12

657

4563

(3008152) Bicarbonate [Moles/volume] in Arterial blood

441

2554

1.80

27.47

8.7

6.9

24.44

24.45

mmol/l

0.02

423

2440

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

210

936

2.30

27.14

1.7

1.6

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

4066

37416

1.58

27.11

6.4

5.2

1.92

1.90

mu/l

0.41

3795

34800

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3212

28230

1.42

27.05

4.8

3.3

55.73

47.40

u/l

5.21

3056

26655

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1313

9897

1.45

26.78

1.4

1.3

1.18

1.74

u/ml

1.65

318

2665

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

272

1353

2.07

26.70

8.8

4.8

1.80

1.47

mg/l

5.25

253

1253

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

205

915

2.30

26.41

1.9

1.5

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

274

1378

2.05

26.10

2.7

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

8.01

25.99

12.9

13.2

5.48

5.94

mmol/l

0.36

(4198724) Urine methamphetamine measurement

176

4.08

25.80

2.9

1.9

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

3014

26300

1.39

25.73

3.6

3.1

—

(3028026) IgM [Mass/volume] in Serum or Plasma

447

2648

1.76

25.73

2.1

2.0

1.24

1.36

g/l

0.46

416

2439

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

246

1196

2.11

25.65

4.3

3.5

6.49

2.88

ratio

0.65

148

678

(3034860) Kappa light chains.free [Mass/volume] in Serum

268

1350

2.04

25.42

4.4

3.6

68.21

94.49

mg/l

0.27

235

1152

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

267

1347

2.04

25.22

4.4

3.6

36.62

63.03

mg/l

1.45

233

1152

(3011288) Drugs identified in Urine by Screen method Nominal

254

1265

2.06

24.85

5.7

2.4

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

235

1144

2.11

24.42

1.9

1.7

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1038

7603

1.47

24.21

1.4

1.3

37.16

30.26

iu/ml

0.37

285

2287

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

228

1106

2.11

23.92

1.9

1.6

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

279

1461

1.97

23.72

2.4

1.8

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

220

1056

2.14

23.72

1.5

1.4

—

(3005322) IgE [Units/volume] in Serum or Plasma

458

2797

1.70

23.58

1.5

1.3

586.02

251.03

u/ml

1.55

428

2597

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

297

1592

1.92

23.57

2.6

2.0

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

763

5284

1.53

23.33

2.1

1.8

1.59

1.46

5.07

662

4651

(3048929) Epstein Barr virus Ab [Presence] in Serum

282

1501

1.93

22.85

1.5

1.3

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

260

3.31

22.75

1.6

1.4

153.33

525.45

titre

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

184

836

2.25

22.75

1.9

1.5

138.87

148.14

au/ml

0.49

240

(3004809) Band form neutrophils/Leukocytes in Blood

156

672

2.37

21.84

3.0

3.7

1.21

1.35

0.25

139

603

(3013512) EKG study

1691

13699

1.36

21.58

4.5

3.5

0.83

0.75

—

(3025941) Bacteria identified in Stool by Culture

375

2220

1.75

21.55

1.4

1.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

269

1438

1.92

21.52

5.5

1.9

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

4123

38464

1.52

21.50

28.2

14.9

81.65

82.48

ml/min/173m2

1.38

3884

35486

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

123

479

2.61

21.37

1.4

1.2

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

202

980

2.11

21.20

1.3

1.2

1.57

5.38

u/ml

—

(3037756) Immunofixation for Serum or Plasma

177

819

2.21

20.95

2.0

1.7

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

178

828

2.19

20.80

1.6

1.4

—

(3028626) Oxygen [Partial pressure] in Capillary blood

233

1206

1.98

20.49

5.6

4.6

8.50

8.42

kpa

0.29

227

1179

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

331

2.91

20.42

1.3

87.80

80.49

—

(3042733) HLA Ab [Presence] in Serum

144

3.99

20.25

5.2

4.9

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

349

2.85

20.25

1.9

1.4

1.15

1.29

promille

0.39

276

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

162

3.80

20.22

1.1

221.67

209.13

iu/ml

0.13

162

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

295

1665

1.82

19.91

3.1

2.4

3.76

3.72

g/l

0.13

267

1528

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

295

1666

1.82

19.87

3.1

2.4

4.21

4.20

g/l

0.05

268

1527

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

295

1666

1.82

19.87

3.1

2.4

7.44

7.35

g/l

0.38

267

1527

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

147

647

2.31

19.63

1.4

1.2

—

(3020891) Body temperature

328

1919

1.76

19.62

6.8

4.3

36.92

36.91

°c

0.09

321

1904

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

290

3.00

19.60

2.0

1.5

24.72

21.51

u/ml

0.27

(3047181) Lactate [Moles/volume] in Blood

239

1269

1.93

19.51

6.9

6.3

1.27

1.33

mmol/l

0.37

217

1113

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

263

1441

1.87

19.51

3.1

2.4

10.09

10.30

g/l

0.30

231

1289

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

187

911

2.10

19.43

1.6

1.3

279.71

253.95

u/ml

0.58

128

551

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

503

3298

1.59

19.42

4.3

2.6

61.06

67.04

ml/min/173m2

2.24

216

1385

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

4042

37718

1.46

19.41

8.7

6.1

41.43

38.94

mmol/mol

36.73

3791

35482

(3023420) DNA double strand Ab [Units/volume] in Serum

304

1750

1.79

19.22

2.4

1.8

10.90

6.73

iu/ml

0.73

429

(3000570) Elastase.pancreatic [Mass/mass] in Stool

233

1234

1.93

19.17

1.4

254.94

281.36

ug/g

1.01

135

715

(3037121) Protein [Mass/volume] in Urine

262

1444

1.86

19.09

5.6

3.5

405.44

407.98

mg/l

0.01

154

653

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

198

996

2.03

18.88

1.7

1.4

—

(40768797) Stomach Pathology biopsy report

784

5688

1.45

18.69

1.4

1.2

—

(3002619) Bacteria identified in Specimen by Culture

4.57

18.65

1.3

1.2

—

(3000330) Specific gravity of Urine by Test strip

336

2008

1.72

18.64

4.2

3.2

1.02

ratio

0.43

311

1804

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

236

1275

1.90

18.30

1.3

1.2

15.97

45.32

u/ml

1.31

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

275

1559

1.81

18.29

3.1

2.4

2.96

2.92

g/l

0.24

247

1421

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1045

8015

1.39

18.14

3.2

3.0

2.46

2.45

mmol/l

2.93

916

7194

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

246

1353

1.86

18.04

1.7

1.5

0.64

8.24

iu/ml

0.77

246

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1961

16546

1.31

17.98

5.3

3.7

0.08

0.07

estimate

0.10

440

3773

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

938

7074

1.41

17.97

1.3

11.79

10.96

u/ml

0.12

306

2793

(40768446) Kidney Pathology biopsy report

162

3.61

17.91

2.0

1.7

—

(3017181) Myelocytes/Leukocytes in Blood

556

3807

1.52

17.62

5.4

4.5

0.88

0.89

0.05

233

1133

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1084

8404

1.37

17.54

1.9

1.7

4030945.50

27931023.23

pmol/l

3.16

918

7089

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

101

398

2.57

17.20

1.3

1.2

65.22

72.52

u/l

0.33

354

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

191

3.33

17.18

4.1

1.8

148.27

148.16

umol/l

0.00

105

(3020564) Creatinine [Moles/volume] in Serum or Plasma

4471

42831

1.67

17.03

38.4

19.8

84.56

77.74

umol/l

13.49

4427

42334

(40768804) Tissue Pathology biopsy report

1934

16383

1.30

16.88

2.5

2.1

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

130

581

2.27

16.80

1.2

19.60

7.37

u/ml

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

221

1203

1.88

16.75

1.3

18.83

7.97

u/ml

0.61

179

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

220

3.12

16.69

1.2

—

(3016879) Cocaine [Presence] in Urine

289

1711

1.73

16.57

5.9

1.8

—

(3020876) Protein [Mass/time] in 24 hour Urine

114

484

2.39

16.57

3.1

2.6

1.26

1.36

g/24h

0.16

290

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

461

3070

1.56

16.55

1.6

1.4

—

(3017354) Segmented neutrophils/Leukocytes in Blood

105

431

2.47

16.43

3.2

3.7

61.93

56.49

1.75

375

(3029937) Albumin [Presence] in Urine by Test strip

1469

12036

1.32

16.20

5.5

4.0

0.00

estimate

0.25

501

4212

(36660697) Celiac disease serology panel - Serum

509

3481

1.52

16.17

1.2

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

155

757

2.08

16.05

1.8

1.7

—

(3019225) pH of Specimen

541

3755

1.50

16.00

6.3

4.3

7.38

7.35

3.23

409

2724

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

218

1201

1.85

15.93

1.3

16.75

3.43

u/ml

0.41

112

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

250

1452

1.76

15.34

3.2

2.4

0.59

0.96

g/l

1.15

212

1242

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

113

495

2.31

15.33

1.5

1.4

—

(3044889) 12 lead EKG panel

3118

28292

1.29

15.27

4.9

4.0

0.50

7358.11

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

122

554

2.23

15.21

1.9

1.6

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

170

879

1.97

15.06

4.9

1.8

0.82

0.86

nmol/l

0.29

129

749

(3008757) Leukocyte morphology finding [Identifier] in Blood

401

2.45

14.99

3.8

4.1

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

213

1188

1.83

14.97

3.1

2.4

0.00

g/l

-0.00

187

1041

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

110

485

2.30

14.72

1.5

1.4

—

(4024509) Urine culture

299

1847

1.66

14.65

2.3

1.9

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

244

2.85

14.54

3.8

1.8

—

(3024471) HLA-A [Type]

137

3.53

14.42

1.0

—

(3000764) Benzodiazepines [Presence] in Urine

298

1847

1.65

14.42

5.9

1.8

—

(3002179) Metamyelocytes/Leukocytes in Blood

517

3629

1.48

14.41

5.1

4.4

0.81

0.70

0.37

216

1076

(3024522) Salmonella sp identified in Specimen by Organism specific culture

110

491

2.27

14.31

1.5

1.4

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4428

42524

1.56

14.19

19.2

11.8

26.64

26.78

u/l

0.19

4333

41375

(3028300) Cannabinoids [Presence] in Urine

299

1864

1.64

14.14

5.8

1.8

—

(3027008) Opiates [Presence] in Urine

298

1858

1.64

14.09

5.7

1.8

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

198

1101

1.83

14.07

1.2

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

169

893

1.93

14.07

2.8

2.3

147.31

99.20

ug/min

0.68

111

558

(4195642) Thrombophilia screening test

128

615

2.11

13.89

1.2

—

(3024932) HLA-DR beta [Type]

136

3.48

13.84

1.0

1.1

—

(3039000) Anion gap in Blood by calculation

163

856

1.94

13.82

8.1

7.6

11.62

11.31

mmol/l

0.45

151

764

(44816559) Phosphatidylethanol [Mass/volume] in Blood

293

1828

1.64

13.82

1.9

1.7

0.26

0.32

mg/l

1.14

124

886

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

197

1101

1.82

13.78

3.3

2.4

0.00

g/l

-0.00

186

1040

(3018572) Chloride [Moles/volume] in Blood

163

857

1.93

13.78

8.1

7.6

104.42

105.11

mmol/l

0.92

151

765

(3014765) Yersinia sp identified in Stool by Organism specific culture

198

1112

1.81

13.63

1.2

1.1

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

214

1231

1.77

13.60

3.3

2.3

0.00

0.03

g/l

1.92

198

1107

(3003181) Sodium [Moles/volume] in Urine

149

765

1.98

13.50

2.3

1.5

59.01

63.14

mmol/l

0.47

111

623

(3024891) Influenza virus A+B Ag [Presence] in Specimen

198

1116

1.81

13.48

1.3

1.2

—

(3021440) Promyelocytes/Leukocytes in Blood

514

3652

1.46

13.43

5.6

4.6

0.12

0.04

196

980

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

165

880

1.91

13.37

1.6

1.5

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

122

585

2.11

13.32

1.2

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

315

2023

1.60

13.21

2.6

2.4

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

286

1797

1.63

13.12

1.9

2.0

39.02

39.39

u/l

0.11

254

1612

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

433

2.29

13.09

1.4

1.3

1.29

1.47

nmol/l

0.92

389

(42529406) Shigella sp [Presence] in Stool by Culture

197

1120

1.79

13.04

1.2

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

188

3.00

12.99

1.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

116

551

2.13

12.99

1.9

1.5

—

(3042517) Benzodiazepines panel - Urine

9.33

12.94

4.7

2.1

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

179

994

1.83

12.81

3.0

2.2

128.70

129.95

g/l

0.25

137

779

(3049717) Cytology report of Urine Cyto stain

253

1553

1.66

12.72

2.7

2.6

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

994

7933

1.32

12.71

1.8

1.6

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

108

504

2.17

12.66

2.4

2.5

35.12

27.73

iu/ml

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

421

2914

1.49

12.55

2.5

2.4

22.10

21.19

au/ml

0.07

326

(3018405) Lactate [Moles/volume] in Arterial blood

224

1338

1.71

12.48

5.1

3.8

1.41

1.38

mmol/l

0.15

218

1317

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

125

621

2.04

12.45

1.2

1.1

117.22

115.02

0.28

114

572

(44790049) Parainfluenza type 3 nucleic acid detection

118

575

2.08

12.38

2.0

1.5

—

(44790048) Parainfluenza type 2 nucleic acid detection

118

575

2.08

12.38

2.0

1.5

—

(44806118) Parainfluenza type 4 nucleic acid detection

118

575

2.08

12.38

2.0

1.5

—

(44790047) Parainfluenza type 1 nucleic acid detection

118

575

2.08

12.38

2.0

1.5

—

(3045424) Erythrocytes [Presence] in Urine

313

2039

1.57

12.35

2.5

2.2

0.01

0.42

estimate

0.52

636

(3025468) Yersinia sp identified in Specimen by Organism specific culture

101

464

2.20

12.31

1.5

1.4

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

5.81

12.25

1.0

1.3

456.29

350.11

u/ml

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

101

467

2.19

12.13

1.5

1.4

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

157

852

1.87

12.10

1.7

1.4

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

4041

38353

1.35

12.07

6.1

5.0

6.19

5.90

mmol/l

20.68

3760

35409

(3005988) Vibrio sp identified in Specimen by Organism specific culture

101

469

2.18

12.00

1.5

1.4

—

(3023199) Leukocytes [#/volume] in Pleural fluid

104

490

2.15

11.92

1.6

1.4

2435.68

3934.50

e6/l

0.38

350

(3027944) Amphetamines [Presence] in Urine

286

1840

1.59

11.91

6.0

1.8

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

610

4561

1.39

11.91

10.2

6.7

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

145

3.19

11.89

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

162

894

1.84

11.85

4.6

4.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

128

655

1.98

11.76

1.2

1.1

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

250

2.62

11.75

2.5

1.6

14.43

24.15

umol/l

3.03

229

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

5.52

11.63

1.4

1.2

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

390

2699

1.48

11.63

1.3

65.43

53.07

au/ml

0.42

183

(4268621) Lupus anticoagulant assay

100

469

2.16

11.61

2.5

2.3

—

(3003327) Ova and parasites identified in Stool by Light microscopy

241

1504

1.63

11.38

1.7

—

(3025159) Blasts/Leukocytes in Blood

504

3675

1.42

11.38

5.9

4.7

0.12

0.22

0.49

181

915

(3003434) Protein [Mass/volume] in Pleural fluid

112

553

2.05

11.37

1.6

1.5

32.17

32.72

g/l

0.19

104

502

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

460

2.15

11.36

1.6

1.8

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

127

659

1.95

11.23

1.5

1.2

3.86

4.31

u/ml

0.19

294

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

227

2.66

11.22

1.4

1.2

45.82

24.67

u/l

0.66

187

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

130

681

1.93

11.18

1.7

1.4

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

253

1608

1.61

11.10

1.3

1.2

0.55

1.15

u/ml

0.78

124

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

294

2.44

11.04

4.3

3.0

213.79

218.82

e6/l

0.08

244

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

236

2.61

10.92

1.4

1.2

123.63

88.01

u/l

0.72

198

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

175

2.88

10.83

2.9

3.3

1.11

1.12

0.01

175

(3009466) Valproate [Moles/volume] in Serum or Plasma

117

598

1.98

10.82

6.5

6.0

373.32

364.81

umol/l

0.27

106

532

(3002256) Pathology report gross observation

707

5494

1.34

10.73

1.4

1.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

572

4304

1.37

10.70

2.0

1.8

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

3626

34064

1.27

10.69

38.3

18.9

13.96

13.58

45.16

3598

33595

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

555

4159

1.38

10.65

4.0

4.2

18.23

21.44

ug/l

0.11

452

3384

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

294

2.40

10.57

4.2

2.8

519.74

527.75

e6/l

0.04

230

(3007463) Buprenorphine [Presence] in Urine

18.80

10.25

5.8

9.0

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

370

2.21

10.09

3.5

2.7

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

135

743

1.84

10.02

1.1

—

(21491868) Cryoglobulin [Mass/volume] in Serum

157

2.88

9.83

1.1

1.2

0.09

0.27

g/l

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

168

2.82

9.83

2.8

2.2

—

(3004616) Nuclear Ab [Presence] in Serum

103

523

1.99

9.74

1.4

1.2

—

(3022145) Colonoscopy Study observation

612

4719

1.34

9.74

1.5

1.4

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

182

1105

1.67

9.62

2.1

13.46

11.56

mg/l

1.61

173

1029

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

187

2.69

9.61

1.2

1.1

3.33

24.00

u/ml

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

111

582

1.93

9.58

1.3

1.4

22.97

24.90

u/l

0.28

483

(1616796) Gas panel - Central venous blood

159

934

1.73

9.49

6.5

3.8

—

(1761868) Lipid panel - Serum or Plasma

1414

16295

0.81

9.45

3.5

3.0

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

118

3.15

9.44

1.6

—

(21494755) Public health laboratory ask at order entry panel

282

4077

0.67

9.41

1.3

1.4

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

240

1570

1.56

9.35

2.5

2.3

8456.94

5903.46

u/l

0.46

615

(3016650) Hepatitis A virus Ab [Presence] in Serum

129

717

1.82

9.30

1.1

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

185

2.67

9.26

1.9

6.3

56.97

67.11

mg/l

0.52

136

(3011412) CD3 cells [#/volume] in Blood

417

2.08

9.24

3.8

2.7

1207.82

1170.22

e6/l

0.14

360

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

294

2.30

9.21

1.9

1.8

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

160

950

1.71

9.20

1.3

1.2

38.89

43.00

u/ml

0.15

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

175

1068

1.66

9.09

2.4

1.9

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

121

665

1.84

9.06

1.5

1.2

2.38

4.14

u/ml

1.38

233

(3045788) Cell count panel - Pleural fluid

407

2.08

9.06

1.6

1.4

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

253

2.39

9.04

3.1

2.8

36.83

41.32

0.95

140

(3007566) Smooth muscle Ab [Titer] in Serum

197

1241

1.61

9.02

1.2

1.3

67.33

102.75

titre

1.80

120

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

483

1.99

8.98

1.2

1.1

97.18

96.75

0.05

458

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

104

549

1.91

8.83

2.3

1.8

10346.67

858.18

titre

—

(3012501) Base excess in Blood by calculation

147

864

1.72

8.79

7.5

4.1

2.93

2.53

mmol/l

1.07

578

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

501

1.96

8.78

1.7

1.6

278.58

349.53

mu/l

2.43

403

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

214

1387

1.57

8.70

1.4

1.3

168.73

217.34

miu/ml

1.10

647

(3014271) Vancomycin [Susceptibility]

169

2.68

8.62

3.5

2.6

—

(3032057) Clostridioides difficile [Presence] in Stool

3.73

8.60

2.1

2.0

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

323

2.18

8.57

4.4

2.4

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3938

37622

1.26

8.53

5.0

4.2

1.37

1.29

mmol/l

9.04

3667

34897

(21494890) Protein electrophoresis panel - 24 hour Urine

397

2.06

8.49

2.4

2.2

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

137

2.86

8.46

2.8

2.2

105.07

65.33

ug/l

1.29

132

(3004775) Volume in Urine collected for unspecified duration

287

2.25

8.40

2.7

2.1

740.79

632.72

1.25

192

(3026389) Candida sp identified in Specimen by Organism specific culture

105

566

1.87

8.38

1.5

1.3

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

144

2.79

8.31

3.2

2.8

0.62

0.61

mmol/l

0.46

144

(3035320) C reactive protein [Mass/volume] in Body fluid

322

2.16

8.23

3.1

2.7

29.35

30.63

mg/l

0.09

227

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

356

2.10

8.17

1.3

1.2

193.33

169.09

titre

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

123

704

1.77

8.10

1.1

88.66

935.01

iu/ml

0.50

147

(3012441) Differential panel - Pleural fluid

420

1.99

8.00

1.6

1.5

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

237

2.34

7.94

1.6

13.44

6.07

u/l

0.93

197

(3004716) Salmonella sp identified in Stool by Organism specific culture

287

2019

1.45

7.91

1.3

—

(4035726) Immunohistochemistry procedure

465

3549

1.34

7.89

1.6

1.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

418

1.98

7.75

1.7

1.8

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

377

2.03

7.75

1.4

1.3

365.24

352.35

u/l

0.07

361

(3035941) MCH [Entitic mass]

4515

44063

1.44

7.69

46.2

23.2

30.17

30.32

6.08

4466

43619

(3000060) B lymphocytes [#/volume] in Blood

139

2.75

7.69

5.8

2.5

0.14

0.23

e9/l

1.13

(3024731) MCV [Entitic mean volume] in Red Blood Cells

4515

44065

1.44

7.67

46.3

23.3

91.00

90.92

0.50

4466

43622

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

578

4568

1.30

7.67

2.6

2.1

—

(3007461) Platelets [#/volume] in Blood

4514

44056

1.44

7.64

46.5

23.4

253.35

250.10

e9/l

2.43

4448

43185

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

4515

44068

1.44

7.64

47.9

23.8

39.53

41.02

9.63

4466

43605

(3000963) Hemoglobin [Mass/volume] in Blood

4516

44080

1.44

7.63

46.9

23.5

131.58

135.97

g/l

64.57

4470

43645

(3026361) Erythrocytes [#/volume] in Blood

4515

44069

1.44

7.63

46.4

23.3

4.41

4.52

e12/l

34.80

4438

43067

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

123

2.86

7.62

1.5

9.47

8.78

ug/l

0.46

123

(3010813) Leukocytes [#/volume] in Blood

4515

44073

1.44

7.58

46.5

23.4

7.06

6.73

e9/l

18.88

4433

43061

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

625

5000

1.29

7.55

2.7

2.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

121

705

1.73

7.52

1.9

1.7

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

164

2.57

7.49

1.3

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

164

2.57

7.49

1.3

1.4

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

594

4726

1.29

7.49

5.1

4.8

32.26

32.19

0.05

420

3176

(3028308) Erythrocytes [#/volume] in Pleural fluid

439

1.93

7.41

1.7

1.4

25302.10

81432.03

e6/l

1.88

251

(3009214) Lutropin [Units/volume] in Serum or Plasma

205

1366

1.52

7.41

1.7

1.4

9.62

9.14

u/l

0.17

162

1081

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

201

2.40

7.41

1.6

2.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

201

2.40

7.41

1.6

2.1

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

201

2.40

7.41

1.6

2.1

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

353

2607

1.38

7.39

3.3

3.6

4.39

4.51

pmol/l

1.52

325

2333

(3027456) Digoxin [Moles/volume] in Serum or Plasma

130

780

1.69

7.28

3.3

0.84

0.81

nmol/l

0.33

629

(3041096) Erythrocytes [Presence] in Urine by Automated

1365

11936

1.20

7.22

4.6

3.2

0.62

0.11

estimate

0.43

440

3612

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

221

1506

1.49

7.19

3.3

3.7

1285.01

3448.92

u/ml

0.55

195

1307

(3022621) pH of Urine by Test strip

425

3248

1.34

7.15

3.1

2.5

6.04

6.08

0.49

291

2179

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

238

2.24

7.00

1.1

1.08

1.06

ratio

0.39

192

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

4158

40169

1.27

6.99

6.6

5.6

2.55

2.71

mmol/l

26.45

3900

37659

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

175

1143

1.55

6.95

2.0

1.4

488.40

552.51

mg/l

0.74

168

1082

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

201

2.35

6.95

1.6

2.1

—

(3024263) Appearance of Synovial fluid

195

2.37

6.93

1.3

1.7

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

359

1.99

6.91

1.4

178062.06

109470.75

e6/l

0.27

246

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

3.97

6.88

1.2

1.0

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

3.56

6.86

2.0

—

(3023511) Choriogonadotropin [Units/volume] in Urine

126

764

1.67

6.80

1.6

1.3

—

(3036782) Glucose [Moles/volume] in Pleural fluid

410

1.92

6.80

1.4

6.48

6.28

mmol/l

0.21

383

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

248

2.19

6.77

1.2

1.3

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

4.01

6.61

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

324

2.02

6.60

1.2

1.1

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

145

2.56

6.59

1.3

1.2

0.30

0.29

g/l

0.14

117

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

252

2.16

6.52

1.2

1.3

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

287

2096

1.39

6.46

1.6

1.4

28.15

26.18

iu/l

0.39

231

1764

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

6.17

6.45

13.3

14.5

170.55

162.40

e6/l

0.04

(3016750) Collection duration of Urine

221

2.23

6.43

2.7

2.0

508.89

492.85

min

0.59

164

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

335

1.98

6.39

1.2

1.1

—

(3010838) Calcium [Moles/time] in 24 hour Urine

117

709

1.67

6.36

1.9

3.95

4.95

mmol/24h

2.85

104

637

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

336

1.98

6.34

1.2

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

371

1.93

6.33

5.2

3.3

13.76

13.34

index

0.12

221

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

325

2431

1.36

6.32

2.6

2.1

—

(3018333) Ribosomal P Ab [Presence] in Serum

316

2.01

6.31

1.1

—

(3003694) ABO and Rh group [Type] in Blood

1389

12286

1.18

6.30

1.5

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

11.02

6.29

8.1

9.0

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

337

1.97

6.29

1.2

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

378

2895

1.33

6.29

2.7

2.2

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

541

1.75

6.17

1.2

1.3

343.99

327.91

pmol/l

0.11

464

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

3.52

6.15

2.0

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

3.21

6.13

1.2

1.1

—

(3038026) Centromere Ab [Units/volume] in Serum

313

1.99

6.11

1.3

1.2

—

44.74

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

416

3243

1.31

6.11

7.4

3.7

1.23

mmol/l

0.03

373

2813

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

390

1.89

6.10

1.2

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

220

2.19

6.08

1.1

44.14

22.66

u/l

0.52

198

(3006571) Granulocytes/Leukocytes in Synovial fluid

429

1.83

5.97

1.7

1.6

61.30

59.18

0.17

262

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

209

2.21

5.96

2.0

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

209

2.21

5.96

2.0

1.5

—

(40768806) Pleura Pathology biopsy report

415

1.84

5.95

1.6

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

147

2.46

5.93

1.6

2.3

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

147

2.46

5.93

1.6

2.3

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

467

1.79

5.90

2.1

29.84

21.19

mg/l

0.85

162

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

171

1154

1.50

5.89

1.2

1.1

4.04

4.22

0.08

159

(3021387) Prolactin [Units/volume] in Serum or Plasma

227

1621

1.42

5.84

1.7

343.47

285.45

mu/l

0.82

199

1478

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

347

1.91

5.81

1.2

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

326

1.94

5.81

1.9

1.5

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

267

3582

0.73

5.80

1.7

3.46

3.48

mmol/l

0.13

180

2443

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

379

4835

0.77

5.79

1.9

2.0

3.59

3.53

ratio

0.38

292

3697

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

426

1.82

5.79

1.9

1.5

—

(3000285) Sodium [Moles/volume] in Blood

3.01

5.79

1.4

1.2

137.71

139.10

mmol/l

0.69

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

153

1013

1.53

5.78

2.1

1.4

4.05

3.70

mmol/l

1.77

143

950

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

327

1.94

5.76

1.2

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

422

1.81

5.66

3.6

3.8

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

4095

39670

1.22

5.59

5.9

5.0

4.41

4.61

mmol/l

32.10

3866

37332

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.94

5.56

1.0

1.1

—

(3016038) Potassium [Moles/volume] in Urine

297

1.96

5.53

2.2

1.2

40.59

34.66

mmol/l

0.74

267

(3044927) Protein electrophoresis panel - Urine

383

1.84

5.48

1.4

1.2

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

149

994

1.52

5.45

2.5

1.5

27.44

28.70

e6/l

0.03

115

736

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

186

1298

1.45

5.45

1.4

1.3

—

(3044009) aPTT.lupus sensitive (LA screen)

4.86

5.42

1.3

1.2

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

349

1.87

5.40

1.5

1.8

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

349

1.87

5.40

1.5

1.8

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

349

1.87

5.40

1.5

1.8

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

119

757

1.59

5.39

1.6

0.68

0.81

g/l

0.88

102

603

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

148

2.37

5.38

1.6

2.3

—

(3036525) Urea [Moles/time] in 24 hour Urine

7.87

5.34

4.3

4.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

4070

39441

1.21

5.31

5.8

4.9

1.38

1.44

mmol/l

21.03

3816

36906

(3037692) Legionella sp identified in Specimen by Organism specific culture

137

2.42

5.28

1.5

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

214

2.11

5.25

4.6

1.9

26.11

28.51

umol/l

0.66

200

(3027923) C peptide [Moles/volume] in Serum or Plasma

241

2.04

5.24

1.8

1.4

1.20

1.27

nmol/l

0.17

177

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

221

2.09

5.23

1.2

1.1

1595.78

1533.30

miu/ml

0.15

221

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

150

1012

1.50

5.22

2.6

1.6

3261.22

1169.89

e6/l

0.33

121

795

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

269

1.98

5.20

1.3

1.2

—

(3023419) Bacteria identified in Sputum by Culture

556

1.67

5.13

3.0

2.6

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

327

1.88

5.11

1.2

1.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

5.20

5.07

3.8

3.3

—

(3028433) Virus identified in Specimen by Culture

129

2.41

4.95

1.4

1.2

—

(3040151) Glucose [Moles/volume] in Capillary blood

478

1.71

4.95

8.6

4.5

8.68

7.21

mmol/l

2.00

399

(3011985) Renin [Units/volume] in Plasma

585

1.64

4.94

1.4

65.07

86.02

mu/l

0.36

528

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1865

17120

1.15

4.92

2.2

1.9

1.46

1.37

mmol/l

3.94

1612

14545

(3042631) Mycobacterium sp identified in Specimen

532

1.67

4.92

3.2

2.8

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

118

2.47

4.86

1.3

1.2

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

168

2.21

4.86

1.0

1.1

89.70

94.77

0.49

133

(3043410) Blood group antigens tested for on Red Blood Cells

113

2.49

4.78

1.7

1.5

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

2.75

4.77

1.4

1.2

100.89

77.60

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

265

1.93

4.72

1.3

1.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

102

2.56

4.70

29.3

6.7

6.55

5.27

kpa

1.14

102

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

171

2.17

4.67

2.8

2.5

136.06

158.03

nmol/l

0.71

153

(3035933) Granulocytes/Leukocytes in Blood

137

932

1.48

4.62

3.8

3.2

56.77

57.95

0.46

137

932

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

332

1.82

4.59

3.5

1.7

5.34

4.22

mg/l

0.66

323

(4015189) Microbial culture of sputum

2.62

4.55

3.6

2.3

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

255

1.93

4.52

1.3

1.5

4.96

6.87

u/l

1.74

227

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

10.01

4.51

2.6

9.9

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

3.27

4.46

1.0

—

(3004451) EKG impression Narrative

222

1.99

4.44

1.3

1.2

—

(3019174) dRVVT (LA screen)

4.06

4.39

1.3

1.2

—

(3006653) Thiamine [Moles/volume] in Blood

237

1.95

4.38

1.3

150.52

131.52

nmol/l

1.58

237

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

412

1.71

4.36

1.3

1.4

—

(3008295) Osmolality of Serum or Plasma

496

1.64

4.35

1.3

1.5

276.42

278.92

mosm/kgh2o

0.44

375

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

2.63

4.22

1.3

1.2

90.25

70.67

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

4.81

4.18

2.8

4.7

2.04

5.51

—

(3047189) Immunofixation for 24 hour Urine

193

2.03

4.17

1.3

1.8

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

147

2.18

4.14

2.4

2.1

23176.92

709.57

e6/l

0.52

108

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

5.89

4.12

5.2

3.9

—

(3033099) Centromere Ab [Titer] in Serum

2.53

4.12

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

271

1.85

4.12

1.7

—

(37208534) Antinuclear antibody arbitrary concentration in serum

135

2.23

4.08

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

135

2.23

4.08

1.3

1.2

—

(37021550) Renin [Units/volume] in Plasma --upright

2.63

4.06

1.1

1.3

212.98

49.03

mu/l

1.25

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

250

1928

1.31

4.05

4.1

3.3

46.55

62.78

u/ml

0.71

239

1860

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

105

1547

0.67

3.99

1.1

0.72

0.64

ratio

0.52

197

(3000093) Morphology [Interpretation] in Blood Narrative

408

1.68

3.98

1.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

113

1639

0.68

3.96

1.1

1.2

1.53

1.52

g/l

0.17

113

1639

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

137

2.20

3.95

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

118

2.30

3.93

1.3

1.2

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

283

1.81

3.92

1.9

1.4

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

131

2.22

3.92

1.3

84.40

85.67

0.05

(3044007) Cell count panel - Peritoneal fluid

131

2.22

3.92

1.8

2.0

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

3.26

3.90

1.1

0.19

0.02

u/ml

0.76

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

142

1009

1.42

3.88

1.1

3.72

2.49

u/ml

0.47

542

(21494434) Karyotype in Bone marrow

382

1.68

3.83

1.3

1.2

—

(3008536) Aspergillus sp Ab [Presence] in Serum

2.48

3.79

1.2

2.2

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

236

1.87

3.77

1.1

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

3565

34437

1.14

3.70

40.4

19.6

331.06

332.78

g/l

22.80

3548

34236

(3028679) Herpes simplex virus Ab [Presence] in Serum

245

1.84

3.69

1.2

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

260

1.82

3.67

1.9

1.5

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

163

1199

1.37

3.66

2.2

1.9

180.63

209.13

pmol/l

3.27

158

1138

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

342

1.70

3.65

1.9

1.5

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

129

2.18

3.63

1.3

1.1

79.43

87.84

0.61

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

150

1090

1.39

3.63

1.1

7.25

5.78

eliau/ml

0.10

143

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

2.54

3.62

1.5

3.0

1.16

1.97

mmol/l

0.58

(3010726) Horse dander IgE Ab [Units/volume] in Serum

119

830

1.44

3.62

1.1

1.31

1.63

u/ml

0.32

430

(3044242) Glucose [Moles/volume] in Arterial blood

233

1.85

3.59

2.6

2.1

8.19

8.25

mmol/l

0.03

233

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

277

1.78

3.57

1.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

123

866

1.43

3.56

1.1

0.92

0.88

u/ml

0.03

392

(3003888) Timothy IgE Ab [Units/volume] in Serum

126

893

1.42

3.52

1.1

5.92

4.61

u/ml

0.40

496

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

5.30

3.50

6.7

6.1

382.00

438.71

umol/l

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

480

1.57

3.45

1.2

1.3

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

333

1.69

3.44

1.4

1.3

1.63

2.47

u/ml

0.47

189

(3003329) Lymphocytes/Leukocytes in Synovial fluid

335

1.68

3.37

1.7

1.5

30.94

30.63

0.02

202

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

141

2.06

3.31

1.4

1.5

17.64

15.21

pmol/l

0.20

121

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

447

1.57

3.27

1.1

—

(44806071) Cardiolipin IgM antibody measurement

2.78

3.25

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

347

1.65

3.23

1.2

110.70

107.39

pmol/l

0.21

347

(3025577) Chromium [Mass/volume] in Blood

220

1.83

3.22

2.0

2.2

3.66

2.19

ug/l

0.52

186

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

106

746

1.43

3.12

1.6

1.7

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

131

2.07

3.11

2.2

2.0

9645.08

17925.11

e6/l

0.23

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

230

1.79

3.11

1.4

1.2

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

351

1.63

3.10

1.2

1.3

1.85

2.11

mmol/l

1.80

329

(3016273) Islet cell 512 Ab [Units/volume] in Serum

3.43

3.10

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.81

3.08

2.2

1.8

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

107

758

1.42

3.05

1.2

1.3

31.98

39.40

u/l

0.35

653

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

376

1.60

3.05

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

159

2082

0.76

3.05

1.7

—

(3017569) Oxygen content in Arterial blood

239

1.76

3.05

2.5

2.4

14.93

16.39

1.88

239

(3034274) Bile acid [Moles/volume] in Serum --fasting

545

1.49

3.01

2.2

2.3

5.98

7.38

umol/l

0.49

395

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

3.55

2.98

1.2

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

351

2930

1.21

2.98

1.2

73.18

138.28

u/ml

5.46

131

1079

(3000012) Reticulocyte production index

623

1.45

2.92

2.5

2.1

0.86

0.90

0.28

414

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

3.71

2.87

1.0

1.1

—

42.20

—

(3017704) Immunofixation for Urine

214

1.78

2.87

2.2

1.6

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

252

1.71

2.84

2.0

1.5

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

338

2826

1.21

2.83

1.3

1.2

—

(3041672) Baker's yeast Ab [Presence] in Serum

3.58

2.78

1.1

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

209

1.78

2.78

1.1

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

597

1.45

2.77

1.1

1.51

1.50

g/l

0.02

544

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

810

0.64

2.70

2.0

1.8

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

510

1.48

2.69

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

219

1.74

2.68

9.7

6.4

31.64

14494.73

u/ml

0.50

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

4.22

2.67

4.4

5.1

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

398

1.54

2.66

1.7

2.6

19.49

19.82

nmol/l

0.10

377

(3008898) HLA-B27 [Presence]

188

1485

1.28

2.66

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.13

2.64

2.0

1.5

0.79

0.24

mmol/l

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

456

1.50

2.62

1.5

1.3

0.42

0.39

g/l

0.19

339

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

497

1.48

2.61

1.4

1.3

—

nmol/l

—

(40758292) HTLV I+II Ab panel - Serum

2.25

2.60

1.3

1.4

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

127

1.97

2.59

4.4

2.6

10.27

10.19

kpa

0.02

127

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

127

1.97

2.59

4.4

2.6

5.04

4.88

kpa

0.30

127

(3027135) IgG subclass 1 [Mass/volume] in Serum

457

1.50

2.59

1.5

1.3

7.13

6.56

g/l

0.41

339

(3028192) IgG subclass 2 [Mass/volume] in Serum

457

1.50

2.59

1.5

1.3

2.55

2.93

g/l

0.98

339

(3023410) Appearance of Cerebral spinal fluid

457

1.50

2.59

3.8

1.8

—

(40762887) Creatinine [Moles/volume] in Blood

3.60

2.57

1.3

1.5

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

3.60

2.57

65.8

4.8

110.44

98.92

g/l

—

(4062490) Immunoglobulin typing, IgG

450

1.50

2.57

1.5

1.4

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.19

2.57

2.2

2.0

16.05

18.04

umol/l

0.32

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

107

2.06

2.56

1.5

1.1

16.82

9.02

pmol/l

—

(3045142) Bone marrow Pathology biopsy report

500

1.47

2.54

1.5

1.4

—

(3034092) Cytoplasmic Ig cells/cells in Blood

2.73

2.54

13.8

8.7

0.25

0.19

0.34

(3002331) Protein [Mass/volume] in Peritoneal fluid

2.13

2.54

1.4

1.2

27.60

25.65

g/l

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

157

1.85

2.51

1.3

1.2

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

3.23

2.51

1.4

4.35

4.16

mg/l

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

3.23

2.51

6.3

4.0

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

406

1.51

2.45

1.0

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

148

1894

0.77

2.45

1.5

1.6

926.53

1013.81

mu/l

0.59

122

1586

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

342

1.56

2.45

1.1

239.98

276.31

mg/l

0.85

293

(3035880) pH of Pleural fluid

218

1.70

2.44

1.4

1.3

7.39

7.40

0.21

153

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.55

2.44

6.2

3.3

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

296

1.59

2.41

1.2

1.1

—

1.53

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

145

1.87

2.41

1.1

12.39

13.37

u/ml

0.07

(3036180) Methadone [Presence] in Urine

6.25

2.37

10.6

1.4

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

353

1.54

2.37

1.2

1.1

37.76

40.89

mg/l

0.36

289

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

510

1.44

2.33

1.4

1.3

0.17

0.22

nmol/l

0.67

410

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

502

1.44

2.32

1.4

1.5

—

(3026051) Granulocytes/Leukocytes in Pleural fluid

2.12

2.28

1.6

1.2

18.00

23.24

0.35

(3020911) Cortisol [Moles/time] in 24 hour Urine

141

1.85

2.27

1.2

1.5

66.62

134.64

nmol/24h

0.85

141

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1515

14222

1.10

2.26

5.3

5.4

2.10

3.09

ug/l

2.33

1361

12926

(4146454) Self-monitoring of blood glucose

414

1.48

2.26

2.9

2.6

—

(40768793) Breast Pathology biopsy report

116

881

1.32

2.25

1.4

1.3

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

598

1.39

2.24

1.4

1.3

0.29

0.31

nmol/l

0.06

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.86

2.20

1.6

3.3

—

(3036670) Protein [Mass/volume] in Synovial fluid

114

1.93

2.20

1.5

1.3

35.69

38.63

g/l

0.31

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

2.24

2.17

1.3

1.5

8.87

483643.88

nmol/l

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

136

1.84

2.17

1.4

147.00

136.97

nmol/l

0.09

103

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

128

992

1.30

2.16

1.2

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

664

1.36

2.12

1.0

1.1

8.03

4.31

u/ml

0.96

301

(3017446) Testosterone [Moles/volume] in Serum or Plasma

463

4080

1.15

2.12

3.0

2.3

12.54

13.38

nmol/l

1.47

417

3694

(3026692) Albumin [Mass/volume] in Peritoneal fluid

116

1.90

2.10

2.0

1.4

11.00

12.79

g/l

0.52

(3027974) Hepatitis B virus e Ag [Presence] in Serum

3.20

2.09

1.8

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

309

1.53

2.05

1.1

1.0

—

0.62

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

238

1.60

2.04

2.6

1.9

172.66

112.52

ng/l

0.61

238

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

695

1.34

2.04

1.4

1.5

0.30

0.39

nmol/l

0.73

534

(3002079) Sodium [Moles/time] in 24 hour Urine

192

1.67

2.02

1.2

1.4

160.83

170.19

mmol/24h

0.17

192

(3020393) Adenovirus Ag [Presence] in Stool

2.23

2.00

2.3

1.7

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

208

1.64

2.00

2.7

1.5

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

100

759

1.32

1.98

1.1

3.44

15.96

au/ml

6.36

195

(3012494) Peanut IgE Ab [Units/volume] in Serum

126

1.83

1.97

1.1

1.2

7.24

2.88

u/ml

0.27

(3014133) Dog dander IgE Ab [Units/volume] in Serum

719

1.33

1.93

1.1

7.67

3.81

u/ml

1.00

367

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

446

1.42

1.92

1.1

—

43.35

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

219

1.60

1.90

1.1

—

(3034426) Prothrombin time (PT)

143

1.75

1.88

1.3

1.2

27.48

28.87

0.54

143

(3052592) Norovirus Ag [Presence] in Stool

2.16

1.87

1.1

1.5

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

220

1.60

1.87

1.2

1.1

—

(3025549) Creatine [Moles/time] in 24 hour Urine

2.86

1.86

1.3

1.5

—

(3006270) Folate [Moles/volume] in Blood

318

1.48

1.83

1.3

1.1

334.58

378.32

nmol/l

0.66

282

(3025130) Human papilloma virus identified in Specimen

588

1.35

1.81

1.8

1.9

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

266

2281

1.18

1.78

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

910

0.73

1.78

1.5

1.6

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

353

1.45

1.78

1.1

—

(40768795) Lymph node Pathology biopsy report

412

1.41

1.76

1.3

1.2

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.50

1.74

1.2

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

188

1569

1.21

1.72

1.5

1.6

21.21

15.49

u/ml

0.48

370

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.67

1.72

7.9

4.3

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

3.85

1.71

1.0

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

629

1.33

1.71

1.1

0.72

0.24

u/ml

0.46

212

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.91

1.69

1.1

1.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.91

1.69

3.6

2.6

207.24

349.29

ug/l

0.15

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

509

1.36

1.69

1.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

275

1.50

1.68

1.0

1.1

0.36

1.25

u/ml

1.28

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.18

1.67

1.7

1.3

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

343

1.43

1.63

1.3

1.4

10.67

8.98

mmol/l

1.31

327

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

3.57

1.61

3.6

7.5

—

(3040893) Potassium [Moles/volume] in Capillary blood

3.57

1.61

3.4

2.4

4.50

mmol/l

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

111

884

1.26

1.59

3.4

3.6

514.22

756.04

u/ml

0.26

102

806

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.33

1.58

2.5

2.7

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

2.69

1.58

1.4

1.5

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

467

1.35

1.53

1.1

—

3.72

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

526

4782

1.11

1.51

1.6

1.5

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.59

1.51

1.9

1.6

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

2.59

1.51

2.3

2.4

0.57

0.59

ug/l

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.81

1.47

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

1.92

1.43

10.2

7.5

10.89

10.50

0.20

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

220

1.50

1.43

1.2

1.3

47.60

69.64

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.82

1.41

1.3

1.20

1.17

mmol/l

0.59

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

149

1.61

1.40

1.5

1.7

40.85

40.67

g/l

0.05

149

(3020874) Milk IgE Ab [Units/volume] in Serum

287

1.43

1.40

1.0

1.1

0.64

2.56

u/ml

1.36

105

(3017509) Phencyclidine [Presence] in Urine

2.25

1.40

5.0

1.8

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.85

1.40

2.5

1.9

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

271

1.44

1.39

1.7

1.5

78.77

83.96

umol/l

0.44

271

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

713

0.74

1.39

1.6

1.5

52.67

59.64

ug/l

0.82

713

(40768800) Prostate Pathology biopsy report

926

0.77

1.37

1.1

1.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

127

1.66

1.36

1.8

1.9

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.87

1.34

1.7

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

167

1.56

1.34

1.2

1.1

11.55

6.20

u/ml

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

2.50

1.30

4.2

5.0

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

251

1.44

1.28

1.0

1.1

0.35

4.05

u/ml

0.83

(40768441) Liver Pathology biopsy report

310

1.39

1.27

2.0

1.5

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.94

1.27

1.5

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

1.94

1.27

3.9

2.0

1.25

1.29

umol/l

0.13

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.05

1.26

1.1

1.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

186

1.51

1.26

1.1

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

261

1.42

1.24

1.3

1.2

0.63

0.57

ratio

0.38

144

(3001186) Copper [Moles/volume] in Serum or Plasma

131

1.61

1.23

2.0

1.3

17.13

16.43

umol/l

0.21

112

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.77

1.22

1.1

1.4

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

331

1.36

1.20

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

297

1.38

1.20

2.0

1.9

1.52

1.54

u/field

0.02

157

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

137

1160

1.19

1.16

1.8

2.1

3.15

8.79

iu/l

0.62

488

(3024869) Neuronal Ab [Presence] in Serum

1.85

1.13

1.0

1.1

—

(1002224) Polysomnography panel

237

2100

1.14

1.12

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

135

1.56

1.11

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

184

1.47

1.10

1.0

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

152

1.52

1.08

1.0

1.2

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1068

0.82

1.07

1.5

55.46

59.26

ug/l

0.39

891

(4034850) Laboratory test

145

1245

1.17

1.06

14.2

9.6

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.93

1.06

1.1

—

(3001729) Color of Synovial fluid

2.12

1.05

1.3

1.5

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.12

1.05

2.9

2.4

1.14

0.61

u/field

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

856

0.80

1.04

1.6

—

(3039443) Prostate specific Ag panel - Serum or Plasma

844

0.80

1.03

1.7

1.6

—

(3005033) Fetal Nuchal fold Thickness US

821

0.80

1.02

1.5

1.18

1.26

0.76

582

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

617

1.24

1.02

1.1

1.49

3.05

—

111

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

1.69

1.01

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.80

0.96

2.9

1.4

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

100

1.60

0.96

1.1

1.3

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.78

0.94

2.6

1.7

—

(40762365) Oxygen content in Arterial blood by calculation

1.78

0.94

2.7

2.8

14.14

15.01

ml/dl

0.49

(3000034) Microalbumin [Mass/volume] in Urine

347

1.30

0.93

2.9

3.0

151.89

50.89

mg/l

0.99

258

(3045683) HLA typing for celiac disease panel - Blood or Tissue

252

1.35

0.91

1.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

116

1350

0.86

0.91

1.5

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

508

0.77

0.90

1.2

1.3

—

(40761536) Microorganisms panel - Urine sediment

361

3325

1.09

0.88

6.3

3.9

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

834

0.82

0.85

1.5

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.94

0.84

1.3

1.8

53.00

44.35

umol/l

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.94

0.84

1.3

—

(40757373) Influenza virus identified in Isolate

1.59

0.84

2.1

1.6

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.70

0.80

1.0

7.81

7.04

u/ml

—

(4094501) Cardiovascular stress test using bicycle ergometer

1150

0.86

0.79

1.1

—

(4281824) Cell count and differential, peritoneal fluid

401

1.25

0.79

1.2

—

(21494814) CD8 cells/Lymphocytes in Specimen

173

1.39

0.78

1.8

2.3

27.92

30.48

0.33

173

(3050129) First trimester maternal screen panel - Serum or Plasma

107

1233

0.86

0.77

1.4

1.5

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

313

1.28

0.77

1.5

1.2

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

315

1.27

0.74

1.1

1.2

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.84

0.73

1.1

1.80

1.83

umol/24h

—

(40765089) Chromosome analysis panel - Blood by G-banded

133

0.60

0.73

1.0

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.80

0.72

2.7

2.1

—

(40765096) Chromosome analysis panel by Banding

142

1.41

0.72

1.4

1.1

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

988

0.86

0.71

1.4

1.5

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

168

1510

1.12

0.71

1.9

—

32.21

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

327

1.26

0.70

1.0

1.1

6.19

9.13

iu/ml

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

997

0.86

0.70

1.5

1.17

1.13

ratio

0.20

603

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.85

0.68

18.6

5.9

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.53

0.68

1.1

1.4

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

136

1.40

0.66

1.2

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

197

1.32

0.65

1.8

1.6

1.63

3.63

u/field

0.84

144

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

1.48

0.64

2.7

3.3

122.33

150.40

ng/l

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

999

0.87

0.64

1.4

1.5

0.95

0.94

ratio

0.04

605

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

999

0.87

0.64

1.4

1.5

1.08

1.17

ratio

0.51

609

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

0.58

0.0

1.0

—

0.12

—

(3011897) Casein IgE Ab [Units/volume] in Serum

1.46

0.58

1.0

1.5

0.01

1.54

u/ml

2.02

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.54

0.53

1.0

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.43

0.52

1.0

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

1.50

0.51

1.2

1.0

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

1.47

0.50

2.1

32.55

32.15

pmol/l

0.01

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.46

0.50

1.0

1.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.49

0.49

1.6

2.0

—

(3013166) Neutrophils/Leukocytes in Synovial fluid

110

1.36

0.48

1.3

52.30

55.90

0.13

(3011544) Albumin [Mass/volume] in Pleural fluid

1.52

0.48

1.6

1.1

15.73

16.91

g/l

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.49

0.47

1.1

1.0

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

588

1.14

0.47

1.1

2.68

3.04

eliau/ml

0.17

267

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

830

8569

0.96

0.46

3.3

3.2

0.72

0.77

ug/l

1.33

564

5527

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

218

1.24

0.46

1.3

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.61

0.43

1.2

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.61

0.43

1.2

1.0

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.61

0.43

1.6

1.5

437.60

327.23

umol/24h

—

(3014891) Appearance of Pleural fluid

1.40

0.42

1.5

1.4

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

341

1.17

0.42

1.5

1.4

159.64

195.24

pmol/l

0.52

341

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.41

0.0

1.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

4.57

—

(1617658) Protocol used for examination of sentinel lymph nodes

277

1.19

0.41

1.0

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

634

1.12

0.40

1.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

159

1.26

0.40

1.4

1.2

920.00

1040.00

titre

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

106

1.32

0.39

1.1

1.4

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

508

1.12

0.35

1.3

7.45

7.13

mmol/l

0.33

451

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.36

0.34

1.0

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

154

1.23

0.33

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

161

1517

1.06

0.31

1.8

4.13

3.99

mg/l

0.10

131

1117

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

1.30

0.30

1.1

1.0

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.27

0.30

1.4

1.5

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

102

1.28

0.30

1.4

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.25

0.29

1.0

1.2

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.25

0.29

1.0

1.1

—

(4133840) Spirometry

108

0.74

0.29

1.5

1.1

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

167

1.20

0.28

1.9

3.0

1.61

1.11

ug/l

0.40

156

(3051387) C reactive protein [Mass/volume] in Capillary blood

834

1.08

0.28

4.3

3.2

32.33

26.94

mg/l

0.64

560

(3002523) Influenza virus A Ag [Presence] in Specimen

796

1.08

0.28

1.2

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

685

0.92

0.25

1.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

198

1.16

0.24

5.6

4.0

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

1.32

0.23

1.0

1.8

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.32

0.23

1.2

1.1

96.00

89.26

titre

—

(44786800) Granulocytes/Leukocytes in Body fluid

1.32

0.23

2.2

1.4

24.00

18.31

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

106

1.23

0.23

1.2

1.3

4.73

436.80

ug/l

—

(3003740) Influenza virus B Ag [Presence] in Specimen

795

1.07

0.23

1.2

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

389

0.90

0.22

4.9

5.3

119.32

63.16

u/ml

0.26

121

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.22

0.22

1.6

1.3

5.66

5.98

mmol/l

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

326

0.89

0.22

1.1

10.59

16.84

u/ml

—

133

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

191

1.15

0.21

1.3

1.2

—

(3048879) Bone marrow aspiration report

107

1.22

0.21

1.6

2.2

—

2.00

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

0.00

0.21

0.0

1.1

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.16

0.21

1.0

1.1

0.01

0.29

u/ml

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.0

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1162

11463

1.02

0.20

4.7

4.4

22.44

21.86

0.59

555

5555

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

1.18

0.19

2.2

1.5

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.15

0.19

1.2

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

109

1.19

0.18

1.0

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

248

0.89

0.18

1.2

1.1

1.08

1.12

u/l

0.15

114

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.19

0.18

1.0

1.2

—

(4211845) Urine protein measurement

195

0.87

0.17

3.8

3.2

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

1.21

0.17

1.1

1.2

0.01

7.73

u/ml

—

(44806420) Estimation of glomerular filtration rate

457

1.07

0.16

2.5

2.4

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

244

0.90

0.14

1.3

1.5

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

169

1.12

0.14

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

131

1.15

0.14

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

202

0.89

0.14

2.0

1.83

2.54

u/ml

—

(3041806) Other cells [#/volume] in Blood by Manual count

141

1.14

0.13

1.3

1.5

0.53

0.49

e9/l

0.22

141

(3013637) Mi-2 Ab [Presence] in Serum

122

1.15

0.13

1.2

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

122

1.15

0.13

1.2

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

122

1.15

0.13

1.2

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

122

1.15

0.13

1.2

1.0

—

(44813793) Dust mix specific IgE antibody measurement

284

0.92

0.13

1.2

1.0

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

126

1.11

0.09

1.2

1.1

—

(3006462) Nitrate [Presence] in Urine

175

0.91

0.08

4.0

3.3

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.03

0.08

1.3

1.1

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

0.81

0.08

1.0

2.14

3.20

kpa

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

0.79

0.08

1.0

8.20

7.45

kpa

—

(3006598) pH of Arterial cord blood

0.79

0.08

1.0

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

599

5934

1.01

0.08

1.6

1.5

—

(3028717) Thiamine [Mass/volume] in Blood

1.03

0.07

1.3

63.00

64.76

ug/l

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

1.12

0.07

1.4

22.20

33.70

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.05

0.07

1.1

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.05

0.07

1.1

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.05

0.07

1.1

1.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

128

1.09

0.06

1.2

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

124

1218

1.02

0.05

1.5

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.11

0.05

1.0

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

111

1.08

0.04

2.6

3.2

37.83

44.96

0.41

111

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

111

1.08

0.04

5.2

6.4

6.58

7.87

0.55

111

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

291

0.96

0.04

1.0

36.42

41.81

ng/l

0.47

198

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

291

0.96

0.04

1.0

269.40

311.64

ng/l

0.76

203

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

102

1.08

0.03

1.0

26.35

36.99

iu/ml

0.33

102

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

289

0.97

0.02

1.0

823.74

736.49

ng/l

0.66

195

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

218

0.96

0.02

1.0

1.2

8.33

9.17

mm/h

0.16

218

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

123

1.06

0.01

1.2

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.06

0.01

1.6

1.4

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

116

0.95

0.00

1.2

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.05

0.00

2.9

3.1

—

(3020491) Glucose [Moles/volume] in Blood

295

0.98

0.00

2.6

1.6

9.71

6.63

mmol/l

1.77

203

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

376

1.01

0.00

1.5

1.4

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

0.00

-0.00

0.0

1.0

—

1.00

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3020650) Glucose [Presence] in Urine

150

1.00

-0.00

1.3

1.8

0.07

0.02

estimate

0.29

150

(42870560) Thyrotropin [Units/volume] in Cord blood

0.87

-0.00

1.0

6.53

8.33

mu/l

—

(3051101) Glucose [Moles/volume] in Cord blood

1.02

-0.00

4.8

7.1

16.07

8.35

mmol/l

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

0.26

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

-0.00

0.0

1.2

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.00

-0.00

0.0

1.0

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.02

-0.00

1.0

1.2

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.02

-0.00

1.3

1.1

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

-0.00

0.0

1.3

—

(3042301) Urate [Moles/volume] in Synovial fluid

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint L12_INFECT_SKIN_OTHER and mortality.

Females

Parameter	HR [95% CI]	p-value
L12_INFECT_SKIN_OTHER	2.319 [2.03, 2.65]	< 0.001
Birth year	0.996 [0.99, 1.0]	0.336

During the follow-up period (1.1.1998 — 31.12.2019), 2422 out of 10980 females with L12_INFECT_SKIN_OTHER died.

Males

Parameter	HR [95% CI]	p-value
L12_INFECT_SKIN_OTHER	2.305 [1.95, 2.73]	< 0.001
Birth year	0.983 [0.92, 1.05]	0.608

During the follow-up period (1.1.1998 — 31.12.2019), 2964 out of 12686 males with L12_INFECT_SKIN_OTHER died.

Mortality risk

Mortality risk for people of age

years, who have L12_INFECT_SKIN_OTHER.

N-year risk	Females	Males
1	0.164%	0.433%
5	1.23%	2.133%
10	3.24%	5.789%
15	6.253%	10.672%
20	11.096%	17.629%

Relationships between endpoints

↥

Index endpoint: L12_INFECT_SKIN_OTHER – Other local infections of skin and subcutaneous tissue

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other local infections of skin and subcutaneous tissue

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints